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Over the last decade, global beef production has increased to meet the protein needs of 
the growing population. As a result, the intensification of beef cattle production systems 
has resulted in broad spectrum prophylactic use of antibiotics and growth promoting 
agents. With increased concern around antimicrobial resistance (AMR) and emergence 
of novel pathogenic strains of bacteria, it is critical to understand disease progression 
and associated changes in the microbiome to develop novel therapeutic alternatives to 
reduce antibiotic use and control disease. One such approach that is currently being 
investigated is the development of novel direct-fed microbial strains to outcompete 
pathogens by colonization resistance. Studies were conducted to develop a novel 
direct-fed microbial from the rumen to reduce the occurrence of liver abscesses in beef 
cattle and to investigate the progression of disease before and after an outbreak of 
infectious bovine keratoconjunctivitis (IBK) by longitudinal investigation of the bovine 
ocular microbiome.  
 
To develop direct-fed microbials against liver abscess causing microbes 
(Fusobacterium necrophorum necrophorum and Streptococcus bovis) in the rumen, 
rumen fluid was obtained from fistulated cattle and a high throughput screening 
approach was implemented to isolate candidate bacterial species that inhibit the growth 
of Fusobacterium necrophorum necrophorum and Streptococcus bovis.  Following in-
vitro testing two candidate strains were identified and further characterized as potential 
candidates to be used as alternatives to antibiotics. Additionally, a longitudinal study 
was conducted in a cattle population consisting of 239 calves over 4 time periods to 
characterize changes in the ocular microbiome by sequencing the V4 region of the 16S 
rRNA gene.  Both alpha and beta diversity analysis demonstrated changes in the 
bacterial community structure of the ocular microbiome post perturbation suggesting the 
bovine ocular microbiome is resilient to change. Factors such as age of cattle, time post 
perturbation, and cattle who were infected with IBK all showed a significant difference in 
the bovine ocular microbiome community composition (p < 0.05). Interestingly, bacteria 
who were deemed as “core taxa” were composed of opportunistic pathogens such as 
Mycoplasma spp. and Moraxella spp.  
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1.1 Introduction 
 
Beef has served as a major protein source in human nutrition. Within the last 25 years, 
global beef production has increased exponentially (FAO, 2008). By 2050, the demand 
for meat and milk is expected to double (FAO, 2008). As such, to meet this growing 
demand, production is expected to increase and as a result beef production has 
migrated to more intensive production systems. This increase in intensification has 
resulted in more genetic homogeneity and increased density in animal production 
systems leading to more susceptibility to disease. As a result, such practices have 
increased prophylactic use of antibiotics and growth promotants to ensure animal health 
and performance (McEwen and Fedorka-Cray 2002). With the current concerns of 
antimicrobial resistance and emergence of novel pathogens, new approaches are 
needed to control pathogen colonization and maintain animal health. The studies 
described here attempts to develop a novel direct-fed microbial as an alternative to 
antibiotics to control liver abscesses and characterizes the changes in the ocular 
microbiome during infectious bovine keraconjunctivitis (IBK) by longitudinal investigation 
of the bovine ocular microbiome. Below, is a literature review of studies describing the 
current status of liver abscesses in beef cattle and the bovine ocular microbiome.   
 
 
1.2 Acidosis and Liver Abscess Introduction 
Liver abscesses have become a growing concern within the beef cattle industry 
(Huebner et al., 2019). Current methods have been successful in decreasing the 
occurrences of liver abscesses. However, 10- 20% of cattle are still affected, resulting in 
a huge economic loss to the industry (Nagaraja et al., 2007). Post-harvest, cattle are 
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scored on a scale ranging from 0, A-, A, and A+ depending on the abundance of 
abscesses and scaring present. In brief, cattle who receive a score of 0 are animals 
who have no abscesses or scaring. Whereas, a score of A+ would mean the liver is 
condemned due to having multitude of liver abscesses present.  
 
Currently, liver abscesses are being treated by a prophylactic, tylosin, which falls in the 
macrolide antibiotic family (Nagaraja et al., 2007). While tylosin has had great impact on 
the beef cattle industry, it does have some draw backs. Macrolide antibiotics are widely 
used in human health and the use in human medicine has increased dramatically in 
recent years (Hyde et al., 2001). Thus, the overuse of antibiotic classes, that are also 
used to treat human disease, can lead to antibiotic resistant pathogens. These 
pathogens can resist antibiotics currently used in the medical industry and thus, 
prophylactic use of antibiotics in the beef industry has come under great scrutiny 
(McEwen and Fedorka-Cray 2002).  
 
The current hypothesis of liver abscess formation is described as a dysbiosis of the 
microbiome due to increase availability of fermentable carbohydrates in high grain diets 
leading to an increase in abundance of Streptococcus bovis (S. bovis) in the rumen 
(Constable 2015). S. bovis is a lactic acid producing organism commonly present within 
the rumen (Constable 2015). As such, when fermentable carbohydrates are abundant, 
S. bovis increases in abundance and changes its metabolism to homolactic 
fermentation (Constable 2015), resulting in increased lactic acid production. This shift 
enables the ruminal epithelium to become compromised, as a result of lactic acidosis to 
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occur (Constable 2015). Thus, the ruminal pH drops from ~6.5 to ≤5. This condition 
leads to ruminitis, a condition which dehydrates and “cracks” the epithelial layer of the 
ruminal wall, allowing for Fusobacterium necrophorum, the major pathogen involved in 
liver abscess formation, to enter into the liver via the portal blood flow (Figure 1) 
(Nagaraja et al., 2007). There are two biotypes of Fusobacterium necrophorum 
associated with liver abscesses: biotype A- Fusobacterium necrophorum necrophorum 
and biotype B- Fusobacterium necrophorum funduliforme (Nagaraja et al., 2007). 
However, Fusobacterium necrophorum necrophorum (F. necrophorum) is the primary 
organism associated with liver abscesses in cattle due to the leukotoxin produced by 
this  
 
 
 
Figure 1. Current hypothesis of acidosis formation in fed cattle (reproduced from 
Nagaraja et al., 2007). 
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strain (Nagaraja et al., 2007).  In brief, the leukotoxin produced is primarily cytotoxic to 
neutrophils, macrophages, hepatocytes, and possibly ruminal epithelial cells (Nagaraja 
et al., 2007).  According to Nagaraja et al. (2007), the importance of leukotoxin being a 
virulence factor is the direct correlation between toxin production and laboratory animals 
induced with abscesses (Coyle-Dennis et al., 1979). Prior to reaching the liver via the 
portal blood flow and forming an abscess, F. necrophorum utilizes the by-product of S. 
bovis (lactic acid) for proliferation (Nagaraja et al., 2007). Once in the liver, F. 
necrophorum creates an anaerobic environment by creating a “pocket” or abscess.  
 
In brief, virulence factors, as described above, plays a critical role in penetration, 
colonization and establishment of F. necrophorum (Nagaraja et al., 2007). While the 
liver is extremely vascular and oxygenated as well as full of phagocytic cells, such as 
leukocytes and Kupffer cells, penetration by F. necrophorum is able to occur due to the 
protease and dermonecrotic activity and the cytotoxic effect of the leukotoxin produced 
by F. necrophorum (Nagaraja et al., 2007). Thus, the leukotoxin is able to protect F. 
necrophorum from the highly oxygenated environment and allows for F. necrophorum to 
establish in the liver (Nagaraja et al., 2007). Additionally, the leukotoxin allows for 
protection to F. necrophorum to survive during phagocytosis while synergistically 
working with Acranobacterium pygones (A. pyogenes) to form an anerobic 
microenvironment by impairment of oxygen transport to damaged erythrocytes 
(Nagaraja et al., 2007). A. pyogenes is commonly isolated from liver abscesses 
(Nagaraja et al., 2007). However, A. pyogenes is typically seen in high abundance in 
cattle with condemned livers even when supplemented with tylosin (Nagaraja et al., 
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2007). It is assumed that A. pyogenes does not facilitate F. necrophorum growth but 
rather intensifies liver abscess formation. However, a synergistic relationship between 
F. necrophorum and A. pyogenes has been described by Nagaraja et al. (2007).  
 
1.3 Probiotics and Direct-Fed Microbes (DFM) 
Interest in identifying the microbiome’s potential as a therapeutic agent is rapidly 
growing (Fon and Nsahlai 2013). According to Elghandour et al. (2015) probiotics are “a 
live microbial feed supplement which affects the host animal in a beneficial way by 
improving intestinal microbial balance”. Like probiotics, Direct-Fed Microbes (DFM) are 
live strains of microorganisms which are commonly utilized to impact and improve the 
rumen of production animals (Elghandour et al., 2015). Such microorganisms are used 
to improve the function of livestock productivity (Elghandour et al., 2015).  
 
The two major types of DFMs that are currently used in the rumen include: bacterial or 
fungal strains (Elghandour et al., 2015). Bacterial DFMs can enhance homeostasis 
within the rumen or post-ruminal gastrointestinal tract (Elghandour et al., 2015). Various 
bacterial DFMs have been investigated for their role in maintaining ruminal pH. As such, 
findings have shown that some bacterial DFMs utilize lactate as a substrate, thus 
having a positive impact on ruminal pH (Elghandour et al., 2015). Studies have also 
shown that with certain DFMs, such as Propionibacterium, can modify rumen 
fermentation to increase the amount of propionate present in the rumen (Kung 2006). 
Thus, allowing increase energy flow to the host animal as propionate is the precursor for 
glucose synthesis via gluconeogenesis in ruminants (Elghandour et al., 2015). This can 
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be especially beneficial during early lactation of dairy cows and can be beneficial in 
improving energetic efficiency and ketosis (Weiss et al., 2008).  
 
Colonization resistance against pathogens (Elghandour et al., 2015) is another avenue 
that DFMs can benefit the host. DFMs could compete for resources, or attachment to 
the epithelium against a targeted organism resulting in decreased colonization of the 
pathogen (Elghandour et al., 2015).  Hydrophobic interactions limit the attachment in 
order to protect the animal against pathogens (Elghandour et al., 2015). DFMs can also 
secrete antibacterial compounds, such as bacteriocin and hydrogen peroxide, which 
have probiotic and competitive inhibiting characteristics (Elghandour et al., 2015). 
Recently, a newer mechanism for DFM has been proposed, where the DFM has the 
ability to modulate host immune function (Elghandour et al., 2015). This action is 
thought to occur in immune cells present within the post-ruminal gastrointestinal tract 
(Elghandour et al., 2015). Briefly, once the DFM is administered, the DFM is taken up 
by the intestinal epithelial cells via transcytosis (Elghandour et al., 2015), as a result, 
antigen cells, such as macrophages, engulf the DFM which then stimulates immune 
responses (Dicks et al., 2010).  
 
Fungal DFMs have been used to act as a buffer in rumen fermentation (Elghandour et 
al., 2015).  As such, these changes in normalizing rumen fermentation have shown to 
improve cattle performance. The mode of action for enhancements by fungal DFM is 
described as buffering effects, which keeps the rumen from sharp drops in pH 
(Elghandour et al., 2015). Fungal DFMs have also been shown to scavenge and 
  
15 
remove oxygen present on freshly ingested feed to increase digestion by the anaerobic 
microbes which in turn allows the rumen to become more efficient in nutrient utilization 
(Elghandour et al., 2015). Elghandour et al. (2015) explains that the effects of fungal 
DFMs, especially in regard to buffering, are typically subtle. Added yeast cannot prevent 
lactic acidosis and the effect of fungal DFM on rumen VFA production have been 
inconsistent while the lower gut has not shown any effects with the use of fungal DFMs 
(Elghandour et al., 2015).  
 
1.4 Use of DFMs in beef cattle 
The rumen is a complex environment that has a dense population of microbes. This 
complex community only has a selected number of microbes which have been 
investigated for DFM use. The majority of these investigations have been to manipulate 
fermentation (McAllister et al., 2011), however uses of fungal inoculation have been 
used to improve fiber digestibility (McAllister et al., 2011). As such, many investigations 
have implemented the use of lactic acid utilizing bacteria to increase performance 
(McAllister et al., 2011) by converting lactate to propionate. An example of some of 
these bacteria include Megashaera elsdenii. Additionally, studies have investigated the 
use of DFMs to change VFA profiles by reducing lactic acid production and increasing 
other VFAs produced (Elghandour et al., 2015 & McAllister et al., 2011).  
 
With limited success, DFMs have also been utilized to increase fiber digestion by using 
DFMs such as Ruminococcus flavefaciens or Ruminococcus albus (McAllister et al., 
2011). As described above, DFMs have been developed targeting lactic acid 
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metabolism (McAllister et al., 2011).  Bacteria of such practice include Megashaera 
elsdenii, Selenomonas ruminantium, and Propionibacterium freudenreichii (McAllister et 
al., 2011). According to McAllister et al. (2011), lactic acid-producing (LAB) bacteria are 
present in the majority of DFMs used for cattle production. Current lactic acid-DFM 
products include representatives from the genera Lactobacillus, Streptococcus, 
Pediococcus, and Enterococcus species (McAllister et al., 2011). LAB has become a 
sought after DFM due to being commonly found in the environment as well as LAB its 
industrial tolerant. LAB has a high number of mechanisms to alter microbial 
communities (McAllister et al., 2011). While some of these interactions can disrupt the 
intracellular pH of bacterial competitors, those bacteria are also known to produce 
antimicrobials and as such may have beneficial effects by decreasing colonization of 
pathogens (McAllister et al., 2011).  
 
Additionally, species belonging to genera Bacillus and Bifidobacterium have been 
considered as a potential DFM due to their high heat tolerance and stability (McAllister 
et al., 2011). According to McAllister et al. (2011), Bacillus species have been isolated 
from the rumen. However, they are low in abundancy and play a minor role in cell wall 
degradation. Similarly, Bifidobacterium has been isolated from the rumen but DFM uses 
has come from other isolation sources (McAllister et al., 2011). The role of 
Bifidobacterium in sugar metabolism and starch digestion is limited (McAllister et al., 
2011).  Instead, Bifidobacterium species are known to colonize the gut epithelium and 
prevent the occurrence of entero-virulent organisms (McAllister et al., 2011). Yeast 
cultures such as Saccharomyces cerevisiae have been used to enhance the 
  
17 
performance in dairy cows. Such practices have been used to increase dry matter 
intake, maintain ruminal pH, decrease lactate concentration, and organic matter 
digestibility (McAllister et. al., 2011).  
 
1.5 Macrolide antibiotics  
Macrolide antibiotics have widely been isolated from nature (O̅mura et al., 2002). These 
antibiotics greatly vary in diversity and can contain 8 to 62-membered lactone rings and 
carry one or more sugar moieties (Gaynor et al., 2003). Additionally, they are linked to 
various atoms around the ring (Gaynor et al., 2003).  According to O̅mura (2002), 
macrolides can be simple carbocyclic monolactones as well as complex lactones that 
contain amino nitrogen, amide nitrogen, an oxazole ring or a thiazole ring within their 
skeletons. These group of compounds are a class of natural products that are 
synthesized by bacteria, fungi, and plants (O̅mura et al., 2002). Here, antibiotic 
production is done through fermentation using microbes (Najafpour 2007). 
 
This family of antibiotics are known to treat infections caused by gram-positive bacteria 
(Gaynor et al., 2003). Early use of macrolides showed success in fighting infections but 
also had side effects resulting in increased acid stability. Thus, the antimicrobial activity 
that came with the use of macrolides, such as tylosin, was thought to be a solution to 
infections (Gaynor et al., 2003). However, with the extended use of this family of 
antibiotics, an increase of resistant strains has risen (Gaynor et al., 2003). While the 
understanding of what gene is expressing the resistance in macrolide antibiotics is not 
clearly know, it is thought to be within specific short peptides in the cell (Gaynor et al., 
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2003). According to Gaynor et al. (2003), this could be a rendering effect to cells 
resistant to macrolides, suggesting the underlying mechanisms of inducible resistance 
and the mode of drug-induced inhibition of translation. 
 
The macrolide inhibition of the ribosome is only understood in the most general terms. 
However, the binding site can be defined by the use of crystallographic structures. 
Gaynor et al. (2003) suggest RNA constitutes the primary component of the macrolide 
binding site. Nucleotide residues in domain V of the 23S rRNA interact with the 
macrolide molecule. Hydrophobic interactions are thought to be what contribute to more 
than 25% of the free binding energy of this antibiotic family. Sixteen-membered ring 
macrolides, such as tylosin, are thought to have a double reversible bond with the N6 of 
A2062 (Gaynor et al., 2003), suggesting a mutation for resistance within the 16-
membered ring group. Sugar residues, ketolide binding, and multiple hydrophobic and 
hydrogen bonds can also account for resistance towards macrolides. Inhibition by 
macrolides can be described in four ways. According to Gaynor et al (2003), these 
modes of action include: 1. Inhibition of the progression of the nascent peptide chain 
during early rounds of translation; 2. Promotion of peptidyl tRNA dissociation from the 
ribosome; 3. Inhibition of peptide bond formation; and 4. Interference with the 50S 
subunit assembly.  
  
Bacteria, that are gram-negative, adhere to the surface of the surfaces where they form 
a biofilm through sequential stages (Shinkai et al., 2008). When gram-negative bacteria 
are exposed to macrolide antibiotics such as Erythromycin, bacterial abundance is 
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decreased due to adherence to Type 4 basement membrane collagen (Shinkai et al., 
2008). Macrolides inhibit guanosine diphospho-D-mannose dehydrogenase (GMD) 
production which reduces biofilm formation. However, due to some bacteria being 
located on the interior of biofilm, the bacteria are simply metabolically slowed rather 
than depleted. Therefore, the targeted bacterium can be protected from antibiotics. 
Macrolides given at high concentrations, to show effectiveness in culture, may be 
deemed as ineffective due to interior location. This gives the belief that gram-negative 
bacteria are conventionally resistant. (Shinkai et al., 2008). 
  
In general context, antibiotics are known to kill bacteria, however some can be resistant. 
The two major types of resistant bacteria are intrinsic and acquired resistance. Intrinsic 
resistance entails bacteria whose cell features are responsible for preventing antibiotic 
action. O̅mura et al. (2002), describes this example as a cell envelope present in an 
organism gives rise to low permeability of the cells to many agents, thus making it 
effective against other bacteria. Acquired resistance occurs from mutations within the 
chromosomal genes, plasmids, or transposons. This occurs due to selective pressures 
or by misuse (O̅mura et al., 2002). 
  
Enzymes can cause inactivation of macrolide antibiotics. These described enzyme 
inactivations occur due to degradation of macrolides or an enzyme that catalyzes the 
hydrolysis of various bonds such as C-O, C-N, or C-C (O̅mura et al., 2002). Inactivation 
can also occur with modifications of antibiotics. These occurrences allow an enzyme to 
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catalyze a phosphate or nucleotidyl group from a donor such as ATP to an antibiotic 
(O̅mura et al., 2002). 
 
1.6 Bacteriocins 
Most bacteriocins are unique as they are only toxic to other bacteria which are 
taxonomically related (Riley et al., 2002). Thus, making them differ from antibiotics. 
While little research has been done, close to 99% of all bacteria potentially produce at 
least one bacteriocin (Riley et al., 2002). 
 
Bacteriocins are unstructured until they are exposed to structure promoting solvents to 
form a helical structure (Zacharof et al., 2012). They are cationic molecules that contain 
lysyl and arginyl residues in excess (Zacharof et al., 2012). Bacteriocins from gram-
negative, gram-positive bacteria, and low molecular weight organisms showcase 
various properties. In brief, gram-negative bacteriocins can be characterized using three 
features: an amino-terminal translocation (T), a central receptor binding domain (R), and 
a carboxyl-terminal cytotoxic domain (C). The amino terminal translocation transfers via 
the outer member to the translocator protein. Central receptor-binding binds with a 
bacterial outer member receptor. The carboxyl-terminal cytotoxic domain simply has 
antibacterial activity (Cascales et al., 2007). Gram-negative bacteriocins act upon the 
outer membrane by penetrating the membrane of sensitive bacteria. There are two 
types of gram-negative bacteriocins. Group A colicins which are small, plasmid 
encoded, with a lysis gene. Whereas, group B colicins are large plasmid encoded 
without a lysis gene. Once these two groups enter the target cell, they can act in one of 
three ways: by formation of pores which promote leakage of cytoplasmic compounds 
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and result in cell death, nuclease type which digest DNA and RNA, or digest 
peptidoglycans (Cascales et al., 2007).    
 
Both low molecular weight (microcins) and gram-positive bacteriocins are similar in their 
properties. As they both are ribosomally synthesized and contain hydrophobic peptides. 
Microcins contain a N-terminal leader peptide as well as core peptides. These types of 
bacteriocins are tolerant to heat, extreme pH, and proteases (Rebuffat, 2012). Microcins 
are classified into two types according to their molecular masses and disulfide bonds. 
Microcins do not have a lysis gene and are secreted outside of the bacteria using an 
ATP binding cassette (Duquesne et al., 2007). 
 
Gram-positive bacteriocins are gene encoded bacteriocins with various sizes, 
structures, and properties. The three major types of gram-positive bacteriocins include: 
lantibiotics, non-lantibiotics, and large proteins. Lantibiotics contain peptide substances 
that can be characterized with polycyclic thioether amino acids lanthionine or 
methyllanthionine as well as unsaturated amino acids dehydroalanine and 2-
aminoisobutyric acid (Zacharof et al., 2012). This class of lantibiotics can be further 
grouped based on their structure (linear vs globular) and mode of action. The linear 
structure has a membrane mode of action while the globular structure has a cellular 
enzymatic reaction. According to Zacharof et al. (2012), linear lantibiotic structures are 
positively charged molecules that have flexibility while the globular lantibiotic structures 
have either a net negative or no net charge. Both structures contain heat stable 
peptides that are modified after translation. This results in the formation of thioether 
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amino acids lanthionine and -methyllanthionine which ultimately leads to the 
dehydration of a serine residue. Non-lantibiotics are a positively charged, heat stable 
molecules that has a non-lanthionine containing membrane of active peptides. Two 
classes of non-lantibiotics have been identified, those of which possess an N-terminal 
with a sequence of Try-Gly-Asn-Gly-Val-Xaa-Cys  as well as a subclass (II b) that refers 
to a two-component bacteriocins that requires two peptides to work synergistically in 
order to generate antimicrobial activity (Zacharof et al., 2012). Large protein 
bacteriocins are heat stable molecules that have not been widely investigated. 
According to Nilsen et al. (2003) group A of large protein bacteriocins are bacteriolytic 
enzymes which kill sensitive strains by lysis of the cell wall. Whereas group B of large 
proteins are non-lytic. 
 
1.7 Bacteriocins in Bacillus licheniformis 
Bacillus licheniformis (B. licheniformis) has been isolated from the mammalian 
gastrointestinal tract as it is a gut symbiont. As such, this organism is a gram-positive 
bacterium that has been shown to produce bacteriocin-like peptides (Wang et al., 2017) 
which has been shown to aid in preservation of food from spoilage (Abriouel et al., 
2011). Due to B. licheniformis not being widely investigated for its bacteriocin 
production, there is little information in regard to how and why it is producing 
bacteriocins. Bacillus subtilis (B. subtilis), a closely related bacterial species to B. 
licheniformis, has been investigated for its ability to produce bacteriocins and its mode 
of action. Thus, researchers have used genomic and physiological information from B. 
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subtilis to predict and understand the bacteriocins and their mode of action of B. 
licheniformis (Wang et al., 2017). 
 
 According to Stein et al (Wang et al., 2017), B. subtilis is able to produce more than two 
dozen bacteriocins which contain a variety of different structures.  B. subtilis bacteriocin 
synthesis is activated by phosphorylation which then initiates the sporulation process 
(Wang et al., 2017). According to Wang et al. (2017), this phosphorylation is referred as 
Spo0A-P.  Spo0A is the primary component of the transcriptional activator and 
repressor, which controls close to 120 genes. This gene transcription is the regulator for 
the start of development. Since Spo0A-P is the regulator of other genes, it activates the 
abrB gene which is thought to be coded for starvation-induced processes. This process 
is involved in sporulation and the production of antibiotics as well as degradative 
enzymes (Robertson et al., 1989). This transcriptional activator also helps activate more 
than 100 genes directly as well as indirectly. Since the abrB gene is part of the growth 
development stage, it is only found among cells during the exponential growth. The 
spo0A-P gene mediates the abrB gene throughout the stationary stage. Both spo0A-P  
and abrB genes are speculated to play an important role in Bacillus species during 
bacteriocin synthesis. Thus, insinuating that both spo0A-P and abrB genes are active in 
B. licheniformis (Figure 2). 
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Nisin is a commonly used bacteriocin within the industry and has been investigated in B. 
licheniformis (Zacharof et al., 2012). Nisin’s mode of action includes rapidly binding to 
anionic liposomes (Zacharof et al., 2012). This allows nisin to form pores which interacts 
with the lipid membrane and peptidoglycan precursor lipid II. Which then depolarizes the 
transmembrane electric potential (Zacharof et al., 2012). According to Zacharof et al. 
(2012), the presence of lipid II disrupts the lipid bilayer. Nisin is able to form pores 
during this step and induces transmembrane movement. Nisin can insert the C-terminus 
and its mode of action has been described using a wedge like model. Zacharof et al. 
(2012), describes the wedge like model as follows: the induced pores involve a proton 
motive force driven by co-insertion of lipids and nisin domains. The nisin molecule may 
Figure2. Proposed spo0A-P and abrB gene activation. Reproduced from 
Wang et al., 2017. 
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allow bending of the C-terminal and then insert into the membrane. This then leads to 
disruption of the lipid protein pores. Hydrophobic forces occur and are the driving force 
of rearrangements among the lipid bilayer. 
 
Tests conducted by Cladera-Olivera et al. (2004), demonstrated that B. licheniformis did 
have antimicrobial inhibitors as it was resistant to proteolytic treatments. This suggest 
that B. licheniformis contains unusual amino acids which makes the bacteria more 
resistant to proteases.  Moreover, B. licheniformis was sensitive to pronase E and lost 
activity with Trichloroacetic acid treatment. According to Cladera-Olivera et al. (2004), 
this suggest that B. licheniformis is proteinaceous.  
 
In recent years, Wang et al. (2017), conducted a similar test in which B. licheniformis 
growth was quantified using real-time PCR. Results showed that growth trends were 
similar in the exponential growth stage and minimal growth during stationary stage was 
achieved. During this study, transcription regulators were also tested in hopes to better 
understand bacteriocin production in B. licheniformis. These transcription regulators 
showed significant decreases in the cells during growth (Wang et al., 2017).  
 
Previous studies have also shown that amino acids are essential part of the backbone 
of bacitracin. According to Haavik (1981), 25% of bacitracin molecule branched chains 
are composed of amino acids. In addition to the amino acids, soybean meal added to 
the media confirmed that nitrogen was a main source for bacitracin biosynthesis. 
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Similarly, Anthony et al. (2008), looked at the influence of medium components and 
fermentation condition on the production of bacteriocin by B. licheniformis. Among the 
parameters tested, B. licheniformis showed that it was induced by the production of 
yeast extract. As such, yeast extract supplement showed an increased bacitracin 
production of B. licheniformis when higher concentrations were added to media. 
According to Anthony et al. (2008), this could be due to the availability of amino acids. 
These results concluded the optimal fermentation conditions for B. licheniformis is 
dependent on pH, temperature, and incubation. Optimal conditions were determined in 
this study to be pH of 6.5, growth at 43C for 24 hours with an increase in yeast extract 
concentration (45g/l) (Thangamani et al., 2008). 
 
Alvarez-Ordóñez et al. (2013), investigated the antimicrobial activity of B. licheniformis 
in strains isolated from retail powered infant milk. These findings showed that B. 
licheniformis possesses a bacteriocin like compound called lichenin which inhibits 
pathogens (Alvarez-Ordóñez et al. 2013).  
 
1.8 Bacteriocins in Bacillus pumilus 
The Bacillus group, sensu lato, are considered good producers of antimicrobial 
substances, including peptide and lipopeptide antibiotics, and bacteriocins (Abriouel et 
al., 2011; Stein 2005). With the presence of antimicrobial production in Bacillus strains, 
survival among habitats has been said to double. Bacillus species can be used as a 
food preservative due to their ability to produce antimicrobial peptides. One of the 
species that is of particular interest is Bacillus pumilus (B. pumilus).  
  
27 
 
Antimicrobial peptides that are ribosomally synthesized are commonly referred to as 
bacteriocins (Abriouel et al., 2011), and are a heterologous group of proteinaceous 
substances that are produced by every major bacterial lineage (Abriouel et al., 2011; 
Riley & Wertz, 2002a, b).  According to Abriouel et al. (2011), bacteriocins produced by 
Bacillus species may be the second most important group of bacteriocins behind lactic 
acid bacteria (LAB) as Bacillus species produce an array of antimicrobial peptides with 
different chemical structures (Gebhardt et al., 2002; Stein 2005). While LAB 
bacteriocins has been classified, no classification scheme to date has been made for 
bacteriocin classification in Bacillus species (Abriouel et al., 2011). The Bacilli produce 
a vast diversity of peptides and proteins, thus, little information on the bacteriocin 
amino acid sequences have been described (Abriouel et al., 2011). Bacillus species 
can be classified in both Class I and II of LAB bacteriocins. However, the main 
classification is type A or type B. Type A includes elongated and positively charged 
lantibiotics whereas type B includes globular and noncharged lantibiotics. 
 
B. pumilus is not well characterized for its bacteriocin-like peptides (Abriouel et al., 
2011), however B. pumilus produces a plasmid-encoded peptide called pumilicins 
(Abriouel et al., 2011). Pumilicins are heat stable, up to 121°C for 15 minutes, and 
active within a broad pH range of 3-9 (Abriouel et al., 2011). Additionally, Abriouel et al. 
2011 states that B. pumilus shows antimicrobial activity against MRSA, vancomycin-
resistant, E. faecalis, and other gram-positive bacteria (Aunpad & Na-Bangchang, 
2007).  
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A study conducted by Hill et al. (2009), demonstrated the inhibitory response of a novel 
strain of B. pumilus against marine pathogens. Shrimp aquaculture routinely uses 
antibiotics as a prophylactic and as therapeutic agent to reduce disease. However, the 
overuse of antibiotics causes both the pond and shrimp microbiota to change (Hill et 
al., 2009). Thus, Hill et al. (2009), investigated an alternative approach by looking for 
an isolate from the midgut of the microbiome shrimp. By looking at physiological and 
morphological characteristics, 16S rRNA analysis, and inhibition assays, the 
investigators concluded B. pumilus to be a viable alternative to the use of antibiotics. 
According to Hill et al. (2009), B. pumilus shows results of even being marginally 
inhibitory to itself, as well as other Bacilli species such as B. licheniformis and B. 
subtilis. While in vitro this investigation demonstrated promising results, Hill et al. 
(2009), still suggested an in vivo study is needed to convincingly demonstrate the 
inhibitory effect B. pumilus on marine pathogens.  
 
1.9 Bacillus species in Livestock Applications 
Bacillus strains have been used as probiotics among livestock animals to improve body 
weight and to inhibit colonization of pathogenic bacteria (Abriouel et al., 2011). B. 
licheniformis has been reported to inhibit both S. bovis and Eubacterium ruminantium 
due to its lichenin properties (Abriouel et al., 2011; Pattniak et al., 2001).  
 
In a study conducted by Rojo et al. (2005), B. licheniformis was used in an assay to 
compare amylolytic activity of exogenous alpha-amylase. In addition, B. licheniformis 
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was investigated in vitro to analyze enzyme degradation and digestibility. Results 
demonstrated that amylolytic activity of B. licheniformis to be optimal at a pH range of 
5.0 to 8.0 at 76C. This explains the increased activity of B. licheniformis in the rumen 
under standard conditions (Rojo et al., 2005).  
 
In vitro studies demonstrated a response to ruminal starch digestion with amylase from 
B. licheniformis suggesting its ability to increase in dry matter digestibility (Rojo et al., 
2005). As such, this suggested increased digestibility of B. licheniformis increased 
ruminal digestion and could be considered as an alternative in ruminants fed high grain 
diets.  
 
A recent study found B. licheniformis to be isolated from the rumen of buffalo showed 
inhibition against multiple bacterial species (Pattnaik et al., 2001). With further peptide 
analysis, Pattnaik et al. (2001), found lichenin to be the bacteriocin associated with this 
particular strain of B. licheniformis. Lichenin is a twelve base pair peptide which is 
produced anaerobically during the late logarithmic growth phase. Additionally, lichenin is 
stable under high heat conditions and a broad range of pH. However, the 
crystallography structure of lichenin found among B. licheniformis has not yet been 
identified.  
 
Ultimately, bacteriocins, derived from Bacillus strains, may have a wide array of uses 
and needs further investigations. According to Abriouel et al. (2011), use of Bacillus 
strains in the food industry could be beneficial as Bacilli could solve many of the 
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limitations found in LAB bacteriocins. Additionally, this bacterium has the potential to 
reduce bacterial pathogens identified in the human health sector, improve animal 
health, and promote plant growth (Abriouel et al., 2011).  
 
1.10 Introduction to investigation of infectious bovine keratoconjunctivitis 
With the importance of the role of the microbiome in animal health and productivity 
emerging (Song et al., 2019), more and more studies are developing DFMs to improve 
animal health and performance. However, before using DFMs to manipulate the 
microbiome it is important to understand microbial community changes and how 
dysbiosis of the microbiome affect animal health and productivity. Therefore, studies 
are needed to investigate the microbiome over time to evaluate baseline microbiomes 
and how microbiomes change or adapt due to environmental changes and pathogen 
colonization. Below we summarize studies related to microbial changes during 
infectious bovine keratoconjunctivitis and how longitudinal microbiome studies can help 
better understand microbiome changes and adaptations to pathogens and 
environmental changes.   
   
1.11 Infectious Bovine Keratoconjunctivitis  
A commonly found disease among beef cattle is infectious bovine keratoconjunctivitis 
(IBK), or better known as “pinkeye”. Cattle infected with IBK cost the beef cattle industry 
close to 150 million dollars annually (Whittier et al., 2009). This economic loss stems 
from decreased average daily gain, decreased milk production, as well as treatment 
costs. A study conducted by Whittier et al. (2009), reported that fed cattle with IBK had 
  
31 
a decrease in weaning weight of 19.6 pounds when compared to healthy calves at 
weaning. Additionally, IBK is the most common condition affecting breeding age beef 
heifers where, most cattle who are affected by IBK in both eyes are more prone to death 
due to starvation or death by an accident (Whittier et al., 2009).  
 
 According to Whittier et al. (2009), IBK is a highly contagious disease that causes 
inflammation of the cornea (clear outer layer of the eye), and inflammation of the 
conjunctiva (the pink membrane lining of the eyelids). Ulcerations occur within the eye 
and form what looks like a hole or depression within the cornea. IBK is reported to be 
caused by bacteria, Moraxella and Mycoplasma, but eye irritation must occur first in 
order for infection to become an issue as both opportunistic pathogens are common 
residents among the microflora in the eye. As such, Moraxella and Mycoplasma are 
known as a pre-disposer of the infection. Eye irritation can occur from face flies, which 
feed around the eyes of cattle, or other sources such as tall grass or feed from feed 
bunks (Whittier et al., 2009). Additionally, it is reported that UV light from the sun can 
make cattle with lighter pigment more susceptible to pinkeye as it increases their 
sensitivity and decreases their immune system (Whittier et al., 2009). Examples of light 
pigmented beef cattle breeds are Hereford, Charolais, as well as F1 Baldie crosses. 
Angelos (2010), reported that cattle with more periocular pigmentation, such as 
Brahmans, are less susceptible to pinkeye.  
 
The eye, nose, or vagina can all be infected Moraxella or Mycoplasma, which can be 
secreted and transmitted by contact. Face flies are the primary transmitter of Moraxella 
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or Mycoplasma as they feed around the eyes and nostrils (Whittier et al., 2009). 
Animals could be asymptomatic for Moraxella or Mycoplasma infection (Whittier et al., 
2009). Asymptomatic carrier animals shed Moraxella or Mycoplasma for long periods of 
time, thus infection among healthy animals can occur during the winter months (Whittier 
et al., 2009). 
 
IBK can be treated but has the potential to progress through four stages if left untreated 
(Whittier et al., 2009). “During stage one of IBK, cattle will have excessive tearing and 
increased sensitivity to light. Cattle will frequently blink while having redness along the 
eyelids. Additionally, cattle will often seek shade, decrease feed intake/grazing time, 
and a small ulcer will progress in the center of the cornea. This ulcer will appear as a 
small white spot within the cornea” (Whittier et al., 2009). Stage two consists of an ulcer 
further spread across the cornea as well as the signs described in stage one. During 
this stage, the cornea begins to become cloudy and blood vessels begin to become 
enlarged to help recover the cornea. Thus, the cornea appears pink, giving the disease 
its name (Whittier et al., 2009). Once the ulcer covers most of the cornea, inflammation 
continues into the inner eye, (Whittier et al., 2009), suggesting the progression of IBK is 
in stage three. The eye color changes from its natural brown color to a yellow shade as 
fibrin, a pus like substance, fills the eye. In the last stage (stage four), the ulcer is 
completely through the cornea and the iris may protrude the ulcer. After healing, the iris 
is stuck in the cornea, resulting in blindness (Whitter et al., 2009). Depending on the 
severity, the eye may stay a blue cloudy to white color once the blood vessels recede.  
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Treatment of IBK is crucial in prevention of shedding of Moraxella or Mycoplasma 
further into herds. According to Cullen et al. (2017), prevention of IBK is preferred. 
However, antibiotic treatment is effective in reducing the duration of IBK. Treatments for 
eliminating the duration of IBK can be done as followed: stage one and two can be 
treated with long-acting tetracyclines such as LA200®. According to Whittier et al. 
(2009), the recommended dose is 4.5cc per hundred weight subcutaneously (SQ). 
Additionally, a second injection 48-72 hours later increases the percentage of cattle 
which responds to treatment (Whittier et al., 2009). Veterinarians perform “bulbar 
conjunctival injections” (Whittier et al., 2009), which is an injection of penicillin and 
dexamethasone in the bulbar conjunctiva of the eye. This causes swelling and a bulge 
to form.  Stage three and four can be treated as stated above with the addition of an eye 
patch or suturing the third eyelid over the eye. Benefits of suturing the third eyelid 
include: reducing irritation which reduces tearing and shedding of Moraxella or 
Mycoplasma as well as supporting the cornea (Whittier et al., 2009). 
 
Currently, prevention for IBK has been limited. Proper management practices can 
reduce the occurrence of outbreaks; however, this practice is still limited. According to 
Whittier et al. (2009), controlling flies are essential. Within a given day of moderate to 
heavy fly infestation, cattle can have ten to 20 flies around their eyes at any time 
(Whittier et al., 2009). Prevention methods can include fly tags, insecticide pour-ons, 
back rubbers, and knock-down sprays (Whittier et al., 2009). Manure management, 
through feed additives or dung beetles, can impact decreasing the prevalence of flies. 
Pesticide resistance among flies can increase if the class of drug is not switched from 
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year to year or if flag tags are not removed in the fall. Grazing management and 
keeping pastures clipped also impact the prevalence of IBK. According to Whittier et al. 
(2009), preventing seed head development in pastures, reduces irritation to the eyes of 
cattle as well as reducing the resting areas for flies. Additionally, a good vaccination and 
nutrition program improve the overall fitness of cattle and can reduce the occurrence of 
IBK. Commonly, operations that have nutritional imbalances, including protein, energy, 
vitamin, and mineral deficiencies, have higher outbreak rates of IBK comparatively.  
 
1.12 Moraxella  
1.12.1 Moraxella bovis 
Moraxella bovis (M. bovis), a gram-negative coccobacillus bacterium, and is one of the 
primary implicator of ocular disease in cattle (Angelos et al., 2004). This hemolytic and 
nonhemolytic pathogen is commonly found in nature (Angelos et al., 2004). However, 
according to Angelos et al. (2004), pathogenicity has been found to be associated with 
the expression of pilin proteins and a hemolytic cytolytic toxin (cytotoxin). While M. bovis 
has hydrolytic enzymatic expression, pilin and cytotoxin protein (MbxA). According to 
Angelos et al. (2007), MbxA is encoded with a classical RTX operon which is comprised 
of mbxCABStolC. These cytotoxins cause corneal ulceration due to the bacterium being 
RTX (repeats in the structural toxin) which is lytic for bovine neutrophils, erythrocytes, 
lymphocytes, and corneal epithelial cells (Angelos et al., 2004).  
 
1.12.2 Moraxella bovoculi 
Similarly, Moraxella bovoculi plays a critical role in IBK, however, the pathogenic role of 
Moraxella bovoculi is unknown (Angelos et al., 2011 & Dickey et al., 2016). According to 
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Angelos et al. (2011), Moraxella bovoculi has a RXT operon that encodes an RTX toxin 
designed to MbvA, which is 83% similar to Moraxella bovis amino acid sequence 
identity to MbxA.  
 
1.13 Mycoplasma 
1.13.1 Mycoplasma bovis 
Mycoplasma bovis plays a critical role in chronic infections. With no vaccine to date 
(Bürki et al., 2015), no prevention can occur. Thus, the use of antibiotics has become 
scarcely efficient. While more common occurrences of Mycoplasma bovis is found 
among cattle diagnosed with bovine respiratory disease, mastitis, or genital disorders, 
the organism has still been found among IBK infections.  
 
According to Bürki et al. (2015), Mycoplasma bovis infection begins with adhesion, thus 
making the interaction with the host cells crucial for survival. Mycoplasma bovis lack 
genes and have a small genome, therefore they acquire essential substances for 
biosynthetic pathways such as amino acids, nucleotides, and lipids (Bürki et al., 2015).  
Additionally, Mycoplasma bovis has different cell invasion interactions. Bürki et al. 
(2015), states depending on the cell type and time of invasion, Mycoplasma bovis can 
be associated with cytosolic side of the cell membrane, with vacuole like structures as 
well as diffuse distribution. Biofilm formation has been observed in Mycoplasma bovis 
strains that are persistent (Bürki et al., 2015). These biofilms have been seen to 
increase reactive oxygen species as well as reactive nitrogen species due to the 
attraction of phagocytes.  
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1.14 IBK intervention studies  
Previously, other researchers have tested the applicability of developing vaccines using 
pilin as a target and have seen pilus-based vaccines to be the most effective in reducing 
IBK (Angelos et al., 2004). Differences in the pilin gene in different serogroups and the 
inversions of the pilin gene has resulted genetic variability across strains, thus, causing 
variability in responses to the pilus-based vaccine when used against other M. bovis 
serogroups.  However, M. bovis cytotoxin appears to be more conserved against 
different strains as hemolysin neutralizing antibodies develop in cattle with IBK (Angelos 
et al., 2004) have shown more consistent results.  
 
A study conducted by Angelos et al. (2004), tested the prevalence of IBK when treated 
with a recombinant M. bovis cytotoxin-ISCOM matrix adjuvanted vaccine. Ulcer area 
measurements were taken, and tear and serum were collected at weeks zero and 
seven. Results found that the recombinant vaccine group showed fewer ulcerated 
calves comparatively to the saline control group up to week 12. By week 20, the 
differences between the two treatments was not significant among the groups (p = 
0.131), but still was the lowest among the recombinant group (Angelos et al., 2004). 
Tear and serum IgA ratios were significantly different between the recombinant vaccine 
nonulcerated calves compared to both the saline and adjuvant nonulcerated calves. 
Age did seem to play a role as calves significantly older in the saline group showed less 
ulcer development by week seven. Calves among the adjuvant and recombinant 
vaccine groups showed no age difference. Ultimately, results suggest that further 
studies need to be conducted. However, M. bovis cytotoxin based vaccines show 
promising results in prevention of IBK (Angelos et al., 2004). 
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Angelos et al. (2010), conducted a second study using a recombinant Moraxella 
bovoculi (M. bovoculi) cytotoxin-ISCOM matrix adjuvanted vaccine to reduce IBK. Novel 
specie of the Moraxella family, M. bovoculi, was isolated from ulcerated cattle. This M. 
bovoculi strain had a similar RTX which encodes an RTX toxin that is designated MbvA 
which had 83% deduced amino acid sequence to MbxA, also known as the M. bovis 
cytotoxin (Angelos et al., 2011). Ulcer surface area measurements and blood serum 
were taken. Results showed no difference among the recombinant M. bovoculi and the 
adjuvant vaccine. However, bacterial isolates from ulcers deemed a larger portion 
showing dominance of M. bovis. According to Angelos et al. (2010), it is possible that 
the M. bovoculi cytotoxin vaccine may be more effective among herds which have a 
majority of IBK cases stemming from bacterium related to M. bovoculi. It is still unsure if 
M. bovoculi is the primary pathogen among IBK cases. Thus, investigating the resident 
microflora of healthy cattle eyes and IBK infected cattle are necessary to establish 
mechanisms of infection and to develop more effective prevention strategies.  
 
In a study conducted by O’Connor et al. (2011), with the primary hypothesis to test M. 
bovis autogenous vaccine did not associate with the incidence of IBK. A secondary 
hypothesis was also implemented in looking at the correlation between receiving the 
vaccination with M. bovis and weight at the end of the study. Both null hypotheses were 
not rejected as no significant difference was seen. Conclusions stated that M. bovis 
autogenous vaccines consistently fail to offer protection. However, there may have been 
some bias in this study as the herd could have developed an immunity to the vaccine. 
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Still, other studies suggest that the autogenous M. bovis vaccines are not universally 
effective (O’Connor et al., 2011). 
  
1.15 Microbiome Analysis in IBK 
With limited investigations on the ocular microbiota and the incidence of IBK, Cullen et 
al. (2017), conducted a study comparing bacterial communities of calves who 
developed IBK in comparison to calves who did not to assess potential causation of 
infection. The main objective of this study was to identify bacterial agents which can 
potentially enhance the occurrence of IBK. To date, this study is the first to look at the 
ocular microbiota in cattle (Cullen et al., 2017). 
 
Cullen et al. (2017), set eligibility requirements for calves to have no ocular lesions at 
enrollment of the study and evaluated the microbiome in IBK using a randomized 
controlled trial. All calves were monitored from June of 2015 to November of 2015 
while still on the dam. The trial consisted of three cohorts: A, B, and C. This division 
was due to the already implanted separation of cattle herds at Iowa State University 
(Cullen et al., 2017). Group A consists of first calving heifers and their parity whereas 
group B and C are mature cows with second or greater parity. Initially, calves from all 
three cohorts were enrolled within the trial as long as they had not shown any IBK 
infection prior to the start of the study. Calves enrolled had eye swabs taken prior to 
the study and after as well as if lesions were present during. Additionally, calves 
enrolled in the study had weights taken at the start and end of the study.  
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Due to the vaccination that was given to the control group being ineffective, cattle were 
intermingled irrespective of if they received a vaccination or not. In both the control and 
enrolled group of calves, eight swabs were selected from each group at random, giving 
16 samples per management groups (Cullen et al., 2017). Calves who had incidences 
of IBK were treated according to manufactures recommended dosage of antibiotics 
florfenicol (Nuflor, Merk Animal Health) or oxytetracycline (Liquamycin LA-200, Zoetis) 
(Cullen et al., 2017). When calves were treated, as a result of IBK, swabs were 
collected from the control group at the same time for microbiome analysis. Equal 
number of swabs from both the enrolled and control group were used for DNA 
extraction and were used for 16S rRNA sequencing using Illumina MiSeq platform. A 
total of 48 samples were analyzed to evaluate microbiome changes during IBK. 
According to Cullen et al. (2017), negative controls were not included into sequencing. 
However, Cullen et al. (2017), made several efforts to reduce experimental errors 
which could cause contamination.  
 
Raw reads were analyzed using the QIIME (v1.9) pipeline (Kuczynski et al., 2011). 
After assembling and quality filtering reads, the dataset included 6,789,231 high quality 
contigs, with 31,963 unique contigs. According to Cullen et al. (2017), alpha diversity 
showed no significant difference in species richness between both the enrolled groups 
and control calves. Additionally, OTU specie richness did not have a significant 
difference among the groups although higher microbial diversity was seen among the 
enrolled group.  
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Microbial composition showed 56.51% of phyla came from Tenericutes, 
Proteobacteria, Firmicutes, and Bacteroidetes. Cullen et al. (2017), states the genera 
frequently associated with IBK, Mycoplasma and Moraxella, were identified as one of 
the top ten most abundant genera found within the samples. Among the control group, 
Mycoplasma and Moraxella were more prevalent compared to the enrolled group.  
 
Among the three groups, alpha and beta diversity showed significant differences within 
species richness.  within groups B and C in comparison to group A when using 
Cohen’s d=1.9 (Cullen et al., 2017). Observed OTUs were significantly different in 
species richness when comparing groups B and C when using Cohen’s d=0.88. 
(Cohen’s d is used to indicate the standard size difference between two means). 
However, no significant differences were reported when comparing the study groups 
when using Faith’s Phylogenetic Diversity analysis. Faiths Phylogenetic diversity can 
be described as the sum of all branch lengths connecting all species to a targeted 
lineage (Faith 1992).  However, there was a clear separation among enrolled groups 
when looking at beta diversity (Cullen et al., 2017). While the microbial composition 
consisted of five abundant phyla including Tenericutes, Proteobacteria, Firmicutes, 
Bacteroidetes, and Actinobacteria, the most abundant genera was Moraxella and 
Mycoplasma. Both Moraxella and Mycoplasma were the most abundant in group B.  
 
Conclusions from Cullen et al., 2017 showed that there were no large-scale bacterial 
community differences between the groups at the genera level. However, Faith’s PD, 
results demonstrated that there was a greater diversity between the enrolled calves 
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and the controls. Additionally, Cullen et al. (2017), concludes that results show 
Moraxella was not significantly different among the controls and the enrolled cattle, 
even though it was one of the more abundant genera. Other studies have shown 
vaccines against both M. bovis and M. bovoculi are not effective in control outbreaks, 
which Cullen et al. (2017), confirmed. Limitations in this study include, dam parity, 
management and organization, timing among collecting samples, and limited 
characterization of the cattle eye microbiota (Cullen et al., 2017). Cullen et al. (2017), 
states that it is difficult to find the correct “window” in identifying a predictive microbiota 
thus, establishing a prediction of when disease may occur is insufficient and the 
samples end up being a measure of the difference in the microbiotas.  Therefore, we 
believe longitudinal studies are needed to better understand microbiome changes and 
the effect of the ocular microbiome change on disease occurrence and progression.  
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2.1 Abstract 
An increase in beef production to meet future food demand has led to an intensified 
production system. This has led producers to implement the use of antibiotics as 
prophylactics in order to ensure animal health and productivity. As a result, the 
antimicrobial resistance (AMR) is at an all-time high and the beef industry has come 
under great scrutiny. Thus, an alternative approach to prophylactic use of antibiotics is 
greatly needed. Probiotics of bacterial origin have been utilized as a natural method to 
replace antibiotics and has shown to improve animal health. Currently, several bacterial 
species have been isolated from the rumen showing promising antimicrobial properties 
in controlling the growth of acidosis forming bacteria Streptococcus bovis (S. bovis) and 
liver abscess forming bacteria Fusobacterium necrophorum necrophorum (F. 
necrophorum necrophorum). In this study, bacterial strains were isolated using various 
isolation strategies and the resulting isolates were subjected to high throughput 
screening to identify bacterial strains with the ability to inhibit both S. bovis and F. 
necrophorum necrophorum. Positive cultures, showing consistent inhibition, were then 
characterized by 16S rDNA sequencing and whole genome sequencing. Of the isolates, 
Generally Recognized as Safe (GRAS) strains were used for further in vitro experiments 
to identify optimal growth conditions and their effects on rumen digestibility. These 
strains are currently being utilized in an ongoing in vivo experiment. This study 
demonstrates the potential of using probiotics as an alternative to antibiotics to control 
acidosis and liver abscesses.  
 
Keywords: probiotics, Generally Recognized as Safe, liver abscesses  
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2.2 Introduction 
By 2050, the global demand for beef as a major protein source is projected to double, 
thus an intensified production system is needed to meet the growing population demand 
(FOA, 2006). As a consequence, the increased prophylactic use of antibiotics to 
manage animal health has resulted in the rise of antibiotic resistant bacteria (Threlfall et 
al., 2000). Thus, novel methods are needed to reduce the use of antimicrobials while 
still maintaining efficient and healthy cattle. One such approach is targeting pathogenic 
and opportunistic pathogenic microbes such as Streptococcus bovis (S. bovis) and 
Fusobacterium necrophorum necrophorum (F. necrophorum necrophorum) using 
bacterial probiotic strains to outcompete the target organism using competitive 
exclusion to replace the use of antibiotics while still improving animal health and 
productivity (McEwen and Fedorka-Cray 2002)  
 
Liver abscesses continue to be a concern among the beef cattle industry (Huebner et 
al., 2019).  While current methods have shown to be effective in reducing the 
occurrence of liver abscesses, 10 to 20% of fed cattle are still affected, causing an 
economic loss to the industry (Nagaraja et al., 2007). Depending on the number of liver 
abscesses and scarring present, cattle are given a score post-harvest ranging from 0 to 
A+. Cattle who are deemed a score of A+ are condemned and ultimately cause a huge 
economic loss in terms of hot carcass weight. A prophylactic antibiotic, tylosin, is being 
used to treat liver abscesses and has been shown to reduce the occurrence of liver 
abscessed up to 70% (Nagaraja et al., 2007). However, tylosin has fallen under great 
scrutiny as it is from the same Macrolide antibiotic family that is widely used in human 
health (Nagaraja et al., 2007). Thus, causing concern that the overuse of tylosin could 
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increase antibiotic resistant bacteria making current antibiotics for human health 
ineffective (Hyde et al., 2001).   
 
The current hypothesis of liver abscess formation is described as a dysbiosis of the 
microbiome due to increase availability of fermentable carbohydrates in high grain diets 
leading to an increase in abundance of Streptococcus bovis (S. bovis) in the rumen 
(Constable 2015). As such, when fermentable carbohydrates are abundant S. bovis 
increases in abundance and changes its metabolism to homolactic fermentation 
(Constable 2015), resulting in increased lactic acid production which compromises the 
ruminal epithelium and causes ruminitis (Constable 2015). Ruminitis is characterized as 
“inflammation of the rumen by a way of carbohydrate engorgement” (Constable 2015). 
Once the rumen epithelial layer is compromised, F. necrophorum necrophorum can 
enter into the liver via the portal blood flow (Nagaraja et al., 2007). Once F. 
necrophorum reaches the liver, F. necrophorum necrophorum begins to create lesions 
which in turn generates abscesses.   
 
Probiotics have gained interest as having potential to increase health and to provide 
beneficial effect in the gut (Hemarajata et al., 2013).  According to Elghandour et al. 
2015, probiotics are a live microbial supplement, which effects the host in a beneficial 
way by improving the intestinal microbial balance. Similarly, directly fed microbials 
(DFM) are live strains of microorganisms or their fermentative products which are 
commonly found within the digestive tract and are used to improve livestock health and 
productivity.  
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This study was designed to isolate beneficial bacteria from the rumen with the 
capabilities to inhibited S. bovis and F. necrophorum necrophorum to reduce the 
occurrence of liver abscesses in fed cattle. To this end, we isolated a large library 
(n=4,692) of strains using various isolation techniques and performed high throughput 
functional screening to identify potential probiotic strains and characterized the identified 
isolates using 16S rRNA sequencing and whole genome sequencing. Finally, we 
performed in vitro and in vivo testing to evaluate the ability of the identified strains to 
reduce S. bovis and F. necrophorum populations and the applicability of the strains as 
direct-fed microbials.   
 
2.3 Materials and Methods 
2.3.1 Rumen fluid collection and preparation of isolation 
All animal-related intervention protocols and husbandry practices were approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Nebraska-
Lincoln and US Meat Animal Research Center under separate IACUC protocols. Rumen 
fluid was collected from fistulated cattle, through the rumen fistula, in animals housed 
within the metabolized area of the University of Nebraska-Lincoln. Rumen samples 
were collected from six different animals from an ongoing study that were fed six 
different diets (Table 1) All collected rumen samples were individually processed 
individually by straining 100mL of rumen fluid through four layers of cheese cloth into a 
thermos to make a total collection volume of 50mL per individual. Each rumen fluid 
sample was prepared individually by mixing 15mL of 1X sterile phosphate buffered 
saline (PBS) with 30mL of collected rumen fluid. The mixture was agitated for five 
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minutes and incubated in a 70C water bath for one hour. After incubation, each rumen 
fluid sample was serially diluted and 50ul inoculants were spiral plated using the Eddy 
Jet spiral plater in duplicate on BD BBL™ ISP1, BD BBL™ ISP2, BD BBL™ ISP4, BD 
BBL™ Brain Heart Infusion (BHI), and Casein Starch media (USBiological Life 
Sciences). Media was prepared according to manufactures directions with the 
modification of adding Cycloheximide (VWR International Solon, OH) at a concentration 
of 50 ug/ml and Nalidixic Acid (ACROS Organics, NY) at a concentration of 20 ug/ml 
prior to pouring of plates to kill vegetative cells.  
 
The plates were incubated both aerobically and anaerobically for up to 96 hours at 
37C. Colonies were picked every 24 hours and placed in 150ul of BHI broth in a 96 
well round bottom plate. Picked colonies were grown for an additional 24 hours and 
25% glycerol was added to each well at a volume of 37.5ul prior to -80C storage. 
 
2.3.2 Functional screening of isolates 
High throughput functional screening of isolates was conducted against Streptococcus 
bovis ATCC 33317 and Fusobacterium necrophorum necrophorum ATCC 25286 on 
bioassay Dish Low Profile plates (Thermo Scientific Rochester, NY) using BHI agar 
medium. In brief, using a sterilized 96 well plate replicator, frozen glycerol stocks of 
isolates in 96 well format were replicated on a pathogen lawn on bioassay plates.  
Between each replication, the plate replicator was sterilized by dipping in 100% ethanol 
and flaming. Six, 96 well plates were replicated on each bioassay plate thus screening 
576 isolates in each plate. The inoculated plates were placed in a 37C incubator (both 
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aerobically and anaerobically) with observation of clearing zones at 24, 36, and 48 
hours. Isolates which demonstrated a clearing zone were identified and used for a 
second round of screening. Secondary screenings were conducted against 
Streptococcus bovis ATCC 33317 and Fusobacterium necrophorum necrophorum 
ATCC 25286 on Mueller Hinton Agar with 5% Sheep Blood plates (Remel Lenexa, KS) 
and grown at 37C for up to 48 hours anaerobically.  
 
2.3.3 DNA extraction and PCR amplification 
Candidate isolates that showed inhibition on both Streptococcus bovis ATCC 33317 and 
Fusobacterium necrophorum necrophorum ATCC 25286 during high throughput and 
secondary screening were grown in 10ml of BHI media at 37C for 24 hours. The 
resulting cultures were used for DNA extracting using the Lucigen Quick Extract 
(Lucigen Corporation Middleton, WI) according to manufactures extraction protocol. 
Extracted DNA was used for PCR amplification of the 16S bacterial rRNA gene in 25μl 
volumes containing 10-25ng of DNA, 0.4 uM of 27F/1492R primer (Baker et al., 2003) 
(27 forward: 5’-AGAGTTTGATCMTGGCTCAG-3’ & 1492 reverse: 5’-
TACGGYTACCTTGTTACGACTT-3’) (Integrated DNA Technologies, Coralville, IA), 
0.75 Units of Terra PCR Direct Polymerase Mix (Clontech Laboratories Inc, Mountain 
View, CA), 1X Terra PCR Direct Buffer (Clontech Laboratories Inc, Mountain View, CA). 
Amplifications were performed on a Veriti 96-well thermocycler (Life Technologies, 
Carlsbad, CA). Cycling conditions include 98℃ for 2 minutes followed by 30 cycles of 
98C for 30s, 58C for 30 seconds, 68C for 45s, with a final extension of 68C for 4 
minutes. Post amplification, 5μl of the PCR product was subjected to gel electrophoresis 
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on a 1.5% agarose gel at 120V for 45 minutes using 6X Blue Bromophenol dye and the 
100 bp ladder to ensure that the correct fragment size was amplified with no mis-
binding. Negative controls with no template was used to detect contamination. No 
contamination was observed.  
 
2.3.4 Sequencing the 16S rRNA bacterial gene for taxonomic identification 
The PCR product was purified to remove unused primers using Shrimp Alkaline 
Phosphatase and Exonuclease I (rSAP & EXO I) (New England BioLabs Ipswich, MA) 
according to manufactures protocol. The cleaned PCR product was then diluted 
accordingly with nuclease-free water to obtain a concentration ranging from 40ng/ul-
60ng/ul. Diluted PCR product was mixed with 4μl of 10uM of primer to make a total of 
12ul that was sent to Eurofins Genomics for sequencing. Resulting data was quality 
filtered and aligned to NCBI non-redundant database using Blastn to identify the 
bacterial species.  
 
2.3.5 Analytical Profile Index (API) testing  
Selected cultures were grown in Brain Heart Infusion medium at 37C, shaking at 150 
rpm, for 24 hours. The resulting cultures were then utilized for API50 CHB/E 
(bioMérieux, USA) and API 20E (bioMérieux, USA) testing according to manufactures 
protocol for biochemical characterization of the strains. The API test kit included 48 
biochemical tests and the test strip results were recoded after 24 and 48 hours of 
anaerobic incubation. The test results after 48 hrs of incubation was analyzed using the 
apiweb interface available at https://apiweb.biomerieux.com.     
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2.3.6 DNA extraction and whole genome sequencing  
DNA was extracted from 1 ml aliquots of overnight cultures (~108 cells) of two selected 
candidate strains using Epicentre’s QuickExtract Bacteria DNA Extraction Kit (Epicentre 
Biosciences, Chicago IL) per the manufacturer’s instructions. Total DNA for each 
sample was quantified on a DeNovix QFX fluorimeter with a DeNovix dsDNA Ultra High 
Sensitivity assay (DeNovix inc. Wilmington DE). A total of 600ng of DNA per sample in 
a 50ul volume was used for Shearing. Nucleic acids were sheared to ~750bp using a 
Diagenode Bioruptor (Denville, NJ), with the power setting on low and cycle conditions 
at 30 seconds on/90 seconds off for 6 minutes.  Sheared DNA was used to prepare 
sequencing libraries using the NEBNext Ultra II DNA Library Prep Kit for Illumina (New 
England Biolabs inc., Ipswich MA) per the manufacturer’s instructions. After quality 
control analysis, libraries were sequenced on the Illumina MiSeq platform using V2 500 
cycle kit using 250bp paired-end sequencing strategy.  
 
2.3.6.1 Sequencing Quality Control, Genome Assembly and Annotation 
Raw reads from the MiSeq sequencing run underwent quality control using Sickle 
software (Joshi and Fass 2011) using default parameters. The sliding window was 0.1% 
of the total read length, and low-quality bases were trimmed from both the 5’ and 3’ 
ends of the read. Quality controlled reads were then assembled using SPAdes 
(Bankevich et al., 2012) (v.3.12.0) using additional options “-k 21,33,55,77,99,127” “--
careful”, to optimize assembly. Genome assemblies were then passed through 
additional quality control software QUAST (v.4.0) (Gurevich et al., 2013) to visualize 
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parameters, and then contamination was assessed using CheckM (v.1.0.18) (Parks et 
al., 2015) software to search for genome completeness and contamination. Assembled 
genome sequences were then searched for open reading frames and genes and 
annotated using Prokka (Seemann 2014). The resulting genome assemblies were 
screened against Bagel4 (van Heel et al., 2018) and bacitbase (Hammami et al.,2010) 
to identify potential bacteriocins produced to gain insight into how these DFM strains 
may inhibit F. necrophorum and S. bovis.  
  
2.3.7 Harvesting of isolate for in vivo study  
Large batch growth and harvesting of the selected isolate(s) (or direct fed microbial 
(DFM)) was performed by growing the DFM in BHI at 37C, shaking, for 48 hours in 1L  
volumes. At the end of 48 hrs of growth, Invitrogen’s Live/Dead Assay (Life 
Technologies Corporation Eugene, Oregon) was used to estimate bacterial cell 
concentrations in the medium using flow cytometry. Flow cytometry was performed at 
the UNL Flow Cytometry Facility. Once concentration was determined, calculations 
were made to contain a minimum cell concentration of five billion cells (5 X 109) per mL 
and 20% of sterile glycerol was added to culture for storage at -80C until fed.  
 
2.3.7.1 Flow Cytometry  
Invitrogen Live/Dead Assay (Life Technologies Corporation Eugene, Oregon) was used 
to estimate cell concentration as an alternative to estimating colony forming units 
(CFUs). Spherotech 5.14 μm beads (Sphero ACFP-50-5 Spherotech Inc. Lake Forest, 
IL) were used as a concentration reference while conducting the flow cytometry in order 
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to determine how many particles were drawn within each pressurized flow cytometry 
analysis run. Stained cells were counted using the FACS Aria II instrument at the 
University of Nebraska-Lincolns Nebraska Center for Biotechnology flow cytometry 
facility. Calculations for exact number of cells per milliliter was performed using the 
equation described below: 
 
[(
Bacterial Cell Count
Bead Count
) × (
Bead Constant
Dilution Volume
) × (Dilution of cell volume) × (Dilution of stain)] × 1000 
 
2.3.7.2 in vivo study 
A 179 day preliminary trial was conducted at United States Meat Animal Research 
Center (USMARC) to evaluate the impact of the DFM developed to reduce liver 
abscesses. Briefly, a cohort of 296 steers on a finishing, high concentrate diet (Table 8) 
with no tylosin feeding were used in this study with a starting average weight of 869 lb. 
The 296 animals were randomly distributed into 10 pens. The study contained two 
treatment groups which included a DFM group (n=148, 5 pens) which was provided the 
test GRAS approved DFM at a minimum concentration of five billion cells/head/day. For 
the first 89 days of the study, Bacillus pumilus (B. pumilus) was top dressed by spraying 
the DFM. From day 90 onwards a cocktail DFM containing B. pumilus and Bacillus 
licheniformis (B. licheniformis) was fed due to synergistic effects observed in vitro 
against S. bovis and F. necrophorum necrophorum. Additionally, a control group of 
cattle was fed the base diet with no DFM supplementation. The control group contained 
148 animals within 5 pens. By day 179, only 288 animals remained on trial due to death. 
Thus, only 288 were analyze with n=146 Control and n=142 DFM.  Deaths that occurred 
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during the trial was due to lameness and not due to the feeding of DFM. During harvest, 
liver scores were collected at the packing facility to evaluate impact of DFM on liver 
abscesses.  
 
2.3.7.3 Collection of rumen fluid from cattle on experimental trial 
All animal-related intervention protocols and husbandry practices were approved by the 
Institutional Animal Care and Use Committee (IACUC) at the United States of Meat 
Animal Research Center. Rumen samples were collected from each animal using 
esophageal tubing as described previously (Paz et al., 2016).  Forty mL of rumen fluid 
was collected and placed into 15mL conical tubes and were snap-frozen in liquid 
nitrogen and stored in a -20C until used for DNA extraction and realtime-PCR analysis. 
Rumen samples were collected on day 89 before feeding the DFM cocktail. 
Simultaneously, similar set of samples were collected from the control animals on day 
89. Additionally, 4 days prior to cattle harvest, rumen samples were collected from both 
cohorts to evaluate the effect of the DFM cocktail on F. necrophorum abundance.   
 
2.3.7.3.1 DNA extraction of obtained rumen fluid 
DNA was extracted from both time periods using the Mag-Bind ® Soil DNA 96 Kit 
(Omega Bio-tek Inc., Norcross, GA, USA) according to the manufacturers’ protocol with 
the following modifications. During the cell lysis step, a bead-beating step was added 
using a TissueLyser (Qiagen Inc., Valencia, CA, USA) for 10 minutes at a frequency of 
20 Hz. Additionally, the tubes were incubated at 95C for 5 min in a water bath. After the 
removal of PCR inhibitors, nucleic acids were precipitated similar to the procedure 
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described by Yu and Morrison (2004) and Paz et al. (2018) and then subjected to 
magnetic bead-based purification as described in the kit.   
 
2.3.7.3.2 Quantitative PCR (qPCR) 
Extracted DNA was quantified using Denovix Fluorescence High Sensitivity Assay 
(Denovix Inc., Wilmington, DE, USA). All samples were diluted to a concentration of 
10ng/ul and was used for quantitative PCR (qPCR) analysis using the Faststart 
Universal SYBR Green Master Mix (Rox) (Roche Basel, Switzerland) according to the 
manufacture’s protocol. Fusobacterium necrophorum specific rpoB gene primers were 
previous described by Jensen et al. (2007) and was used to quantify F. necrophorum 
copy numbers. Forward primer 5’- TCTCTACGTATGCCTCACGGATC-3’ (position 171-
193) and reserve primer 5’-CGATATTCATCCGAGAGGGTCTC-3’ (positions 447-424) 
was used in the qPCR assay for F. necrophorum. The reaction conditions included 95C 
for 10 minutes, followed by 95 C for 10s and 58C for 30s for 55 cycles. A melt curve 
was performed from 65C to 95C in 0.05C increments to ensure the amplification of a 
single product. Additionally, the single copy universal rpoB gene was used to normalize 
for total bacterial abundance as previously described by Santos et al., 2004. Forward 
primer for the universal rpoB consisted of 5′-AACATCGGTTTGATCAAC-3’ and reverse 
5′-CGTTGCATGTTGGTACCCAT-3′ with conditions of 95C for 10 minutes, followed by 
95C for 10s, 53C for 30s, and 60C for 60s with 55 cycles as reaction conditions. A 
melt curve was performed as described above. 
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2.3.8 Digestibility study 
The effect of the DFM on total digestibility in the rumen was evaluated for one of the 
selected DFM strains (B. licheniformis). Feed rations used for testing included dry rolled 
corn, meadow hay, a total mixed ration (TMR), and bran. E. coli was grown and used as 
a control to ensure that increased digestibility is not due to increased cell density of the 
DFM. A modified Tilley and Terry (1963) method was used where rumen fluid and 
McDougalls buffer was mixed at 1:1 ratio after cells of the B. licheniformis, or E. coli, 
and rumen fluid (control) cells were estimated using Flow Cytometry.    
 
B. licheniformis was grown on BHI media shaking at 150 rpm at 37C for 48 hours prior 
to inoculation of rumen fluid used for the in vitro digestibility study. Culture was prepped 
for live/dead cell count using Invitrogen Live/Dead Assay (Life Technologies 
Corporation Eugene, Oregon) according to manufacture protocol and was measured 
using the counted on the ‘FACSAria II’ instrument available at the Nebraska Center for 
Biotechnology Flow Cytometry Facility in Lincoln, Nebraska. Additionally, E. coli was 
grown for 24 hours at 37℃ and cells were counted as described above to ensure 
adequate testing of the effect of B. licheniformis on digestibility.   
 
Briefly, rumen fluid was obtained from a fistulated steer located in the metabolizable 
area at the University of Nebraska-Lincoln and strained through four layers of cheese 
cloth prior to being prepared for a live/dead cell count as described above. Samples that 
included B. licheniformis or E. coli were calculated to bring total cell concentration equal 
to the rumen fluid control. Thus, 63.66ul of B. licheniformis and 66.41ul of E. coli was 
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added to respective samples on a per tube basis. Each treatment was performed in 
triplicate. 
 
As previously mentioned, rumen fluid containing B. licheniformis, or E. coli, and the 
rumen fluid control was mixed at a 1:1 ratio with McDougalls buffer (McDougall, 1948). 
Thirty milliliters of the above mixture was added to plastic tubes containing diet and was 
capped with rubber stoppers to maintain anaerobic conditions. The tubes were 
incubated in a water bath at 39C for 48 hours. To quench the reaction, and stop 
fermentation, 6ml of 20% hydrochloric acid and 2ml of 5% pepsin solution was added 
per tube and then placed back in the 39C water bath for 24 hours. Tubes were 
removed and placed in freezer until subsequent analysis.  
 
Tubes were thawed in a 39C  water bath for 15 minutes and filtered through Watman 
541 filter paper (pore size = 0.22uM). The filtered samples were dried for 24 hours in a 
100C  oven and weighed to determine dry matter digestibility. Additionally, blanks of 
each feed ration were included to adjust for any feed particles that may have originated 
from the rumen inoculum. Filters were placed in crucibles and placed in a mutle ferna to 
determine ash content (Table 3).  
 
2.4 Results  
2.4.1 DFM library isolates 
A library consisting of 4,692 isolates were generated using different culture methods 
from the rumen samples from the 6 animals. The breakdown of the isolates based on 
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the media used included 424 isolates from Brain Heart Infusion, 707 from ISP1 medium, 
1088 from ISP2 medium, 1076 from ISP4 medium, and 1397 from Casein Starch.  The 
resulting bacterial isolates were screened against Streptococcus bovis ATCC 33317 
and Fusobacterium necrophorum necrophorum ATCC 25286 using a high throughput 
approach where the cultures were grown in high density on a pathogen background to 
identify candidate species with the ability to inhibit pathogen growth. Inhibition was 
identified as clearing zones (Figure 1). Our screening strategy allowed us to screen 6 X 
96 isolates (n= 576) in one plate. Of the 4,692 isolates, 81 demonstrated inhibition after 
secondary screening and was further analyzed to characterize taxonomy by sequencing 
the 16S rRNA gene. The 81 isolates that were sequenced (Table 1) were used for 
further in vitro analysis and were prioritized based on their classification of Generally 
Recognized as Safe (GRAS) by the FDA. From the 81 isolates identified, 56 isolates 
were classified as GRAS approved. These isolates can be further classified into 
families, with the predominant family being Bacillus spp.. Two isolates of Bacillus spp. 
with GRAS status were identified as the top candidates based on greatest inhibition 
(Figure 2).  
 
Bacillus species are gram positive, rod shaped bacteria which are spore formers (Voigt 
et al., 2009). They can be grown both anaerobically or aerobically and exhibit a wide 
range of physiological traits (Voigt et al., 2009). Thus, allowing them to flourish in a wide 
variety of environments. Due to Bacillus spp. being spore formers, they have a high 
heat tolerance and can remain stable over a long period of time making them suitable 
for a DFMs as they can undergo thermal processing as feed additives. Additionally, 
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Abriouel et al. (2011) explains how Bacillus species are used to prevent food spoilage 
due to properties such as production of bacteriocin-like peptides (Wang et al., 2017). 
McAllister et. al. (2011) discussed the probability of using Bacillus spp. as DFMs due to 
their ability to form spores to be stable over harsh conditions and their ability to produce 
bacteriocins. However, relatively, Bacillus spp. are low in abundance within the rumen 
and play a minor role in cell wall degradation, from a digestion point of view (McAllister 
et. al, 2011).  
 
The Bacillus spp. identified were tested for optimal growth conditions using elevated 
growth temperatures, starvation, and incubation time. Growth temperatures at 37C, 
42C, 45C, and 50C showed that 37C was the optimal growth condition. M9 Minimal 
Salts 5X (Sigma-Aldrich, St. Louis, MO) was used in comparison to BHI media to 
evaluate if starvation would induce antimicrobial production in the DFM strains 
identified. Clearing zones showed that BHI medium enabled the best inhibition for both 
species. Lastly, both species were grown for 12, 16, 24, 36, 48, 72, and 96 h to identify 
if the stage of the growth curve effects (exponential vs stationary) expression of 
inhibitory products. Optimal growth time for viable cells were at 48 h. All testing for each 
stress factor was performed in duplicate using both shaken (150 rpm) and non- shaken 
cultures. For each stress factor, shaken cultures showed the greatest inhibition. Once 
optimal growth conditions were confirmed, both Bacillus spp. were grown separately 
and in co-culture to see if they worked synergistically. Results showed that both species 
should be grown separately for 48 h but when combined together in a 1:1 ratio and 
screened together, showed the greatest inhibition.  
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2.4.1.1 Biochemical characteristics of the identified DFMs 
To evaluate the biochemical characteristics of the selected DFM isolates, we performed 
Analytical Profile Index (API) testing for each isolate to identify unique characteristics 
present in each isolate compared to know B. licheniformis and B. pumilus strains. The 
API test results for each isolate is shown in Table 5. Interestingly, our B. licheniformis 
(12F) was able to utilize melibiose whereas Logan et al. (1984) did not see the same 
result in the 81 strains of B. licheniformis that they screened. Additionally, our B. 
pumilus strain utilized similar substrates as described by Logan et al. (1984). However, 
substrates such as maltose, sorbitol, starch, glycogen, xylitol and D-turanose showed 
different responses in the B. pumilus strain in comparison to Logan et al. (1984) (Table 
5).  
 
2.4.1.2 Genome Sequencing  
Genome sequencing yielded ~2.69 million high quality 250 bp read-pairs for B. 
licheniformis and ~1.35 million high quality 250 bp read-pairs from B. pumilus strains 
after read QC with Sickle (Joshi and Fass 2011). Sample assemblies showed N50 
values of 152,937bp and 447,432bp for B. licheniformis and B. pumilus strains, 
respectively with the largest contig sizes for each genome being 440,068 and 
447,432bp for B. licheniformis and B. pumilus respectively. A summary for the 
assemblies are shown in Table 6. The B. pumilus draft genome was shown to be 
99.59% complete with 0.83% contamination, with a genome length of 3,760,977bp, and 
would be considered a high quality draft genome. Average nucleotide identity (ANI) 
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comparison to available genomes demonstrated the closest genome to be Bacillus sp. 
WP8 (B. pumilus) with total query coverage and template coverage of 80.98% and 
83.22% respectively. Suggesting this B. pumilus genome to be significantly different 
from other B. pumilus genomes (Table. 7a).  
 
B. licheniformis genome length was predicted to be 3,677,812bp. ANI comparison 
revealed the closest genome to be Bacillus sp. H15-1 with total query coverage of 
87.05% and total template coverage of 96.71%, suggesting that this genome is larger 
than other B. licheniformis genomes (Table 7b). 
 
To identify unique genomic features that may provide insight into how these isolates 
may inhibit F. necrophorum and S. bovis, we screened the genomes to identify 
bacteriocins present within each genome. Briefly, both strains were aligned to Bagel4 
database (van Heel et al., 2018) to search for any bacteriocins associated with either B. 
licheniformis or B. pumilus. Forty-seven contigs were analyzed for B. licheniformis and 
five areas of interests were found. These areas include the class of sactipeptides, 
sonorensin, bottromycin, lichenicidin, and lasso_peptide. Additionally, 14 contigs were 
analyzed for B. pumilus with four areas of interest found including, UViB, UviB, BmbF, 
and amylocyclicin.  A secondary genome screening against the bacitbase database 
(Hammami et al., 2010) confirmed the bacteriocin results obtained by Bagel4 database 
(van Heel et al., 2018).  
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2.4.2 Digestibility study 
A digestibility study was conducted to evaluate if the DFM would inhibit beneficial 
strains and thereby reduce nutrient digestion in the rumen. Using two controls 
consisting of rumen fluid and rumen fluid + Escherichia coli. A DFM added rumen fluid 
sample consisting of Bacillus licheniformis (“12F”) was used to test if there was negative 
effects on digestibility. Feed samples consisted of dried rolled corn, a total mixed ration, 
meadow hay, and bran. Resulting data showed that the rumen fluid with the DFM 
numerically increased dry matter and organic matter digestibility on diets consisting of 
high starch levels (Table 3). As such this data demonstrates that no negative impact on 
digestibility in the rumen due to the addition of the DFM. 
 
2.4.3 An alternative approach for determining cell concentrations 
As an alternative to performing Colony Forming Units (CFUs) we determined cell 
concentrations using live/dead staining and flow cytometry (Figure 3). The isolate grew 
rapidly to acceptable concentrations as such, all batch growths performed met the 
requirement of having at least one billion cells (109) per mL. Thus, in a single growing 
we were able to harvest cells enough for feeding at least 28 days of feeding 148 head.  
 
2.4.4 in vivo study and qPCR analysis 
Realtime PCR analysis was performed on rumen samples collected from DFM fed cattle 
and cattle with no DFM supplementation to evaluate the abundance of F. necrophorum 
in the rumen. Cattle on trial were fed for 179 d with a DFM intervention fed to half of the 
cattle (n=148). Both cohorts did not receive a tylosin prophylactic throughout the entire 
duration of the trial. The DFM cohort was fed a minimum of five billion cells per head per 
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day, with 148 head of cattle divided among five pens. Eight cattle were removed from 
the trial due to death from lameness which resulted in a total of 288 cattle. Rumen 
sampling was performed at day 89 for quantification PCR and day 175. Quantitative 
PCR analysis showed that the presence of Fusobacterium necrophorum necrophorum 
was significantly decreased 100-fold (p < 0.032) compared to control group not 
receiving the DFM during the first sampling (Figure 4). However, after second sampling 
(4 days prior to harvest), there was no significant difference between the two treatments 
(p < 0.382) suggesting that an intervention may need to be fed in higher abundances 
(Figure 4). Additionally, liver scores were given to all cattle on trial post-harvest with the 
percent of abscesses present for DFM and control cohort as follows 21.8% and 18.4% 
(Table 3).   
 
2.5 Discussion 
The growing concern of antibiotic resistant bacteria has brought light on the use of 
probiotics and the additional benefits from this unique approach. Probiotics are live 
supplements which are consumed to enhance the hosts intestinal microbial community. 
Likewise, DFMs are live strains, which can be commonly found within the rumen, that 
have the potential to promote animal health while having additional fermentation 
properties (Krehbiel et al., 2003). Elghandour et al. (2015) demonstrated how DFMs can 
inhibit or prevent the establishment of unwanted pathogens that adhere to the intestinal 
mucosa. Additionally, Elghandour et al. (2015) and Dicks et al. (2010) suggest that DFM 
administered could be used within a hosts immune system by macrophages engulfing 
the DFM and causing an immune response. As such, the use of DFMs could benefit the 
host in many ways. Here we show the potential of identifying new bacterial species with 
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beneficial properties that could be used to improve animal health and productivity while 
reducing the burden on antimicrobial compounds. 
 
2.5.1 Isolating and growth performance in DFM  
A novel approach to antibiotics has become increasingly important with the overuse of 
antibiotics over the past several decades. While this overuse has stemmed from various 
uses, the use of antibiotics as prophylactics in production livestock, has come under 
great scrutiny (McEwen and Fedorka-Cray 2002). Within this study, isolation of DFMs 
as an alternative approach to antibiotics, more specifically tylosin, is demonstrated.  
 
In this study, we isolated 4,692 isolates, from the rumen of healthy fistulated cattle on 
different diets and screened for candidate bacterial species with antimicrobial 
properties. Using targeted inhibition against S. bovis and F. necrophorum we identified 
81 isolates to be effective at inhibiting these two species at varying efficiencies. 
Demonstrating that rumen may be a hotspot for isolating novel DFMs. The 81 isolates 
identified were predominated by the genus Bacillus and belong to 9 different species, 
which included Bacillus pumilus, Bacillus licheniformis, Bacillus gylcinifermentans, 
Bacillus altitudinis, Bacillus safensis, Bacillus clausii, Bacillus circulans, Bacillus 
borstelensis, and Bacillus sororensin. Fifty-six isolates fell into the category of Generally 
Recognized as Safe (GRAS) by the FDA. Interestingly, out of the 56 isolates, the 
predominant family was Bacillaceae. Based on the zones of inhibition among the GRAS 
approved isolates we identified isolate ISP4 P1A 11E (11E) B. pumilus and ISP4 P2A 
12F (12F) B. licheniformis as the top two candidates for further testing. Although, the 
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rest of the discussion will be focused on these two isolates that were the top candidates 
for inhibition of S. bovis and F. necrophorum,  it is noteworthy to mention that our 
bacterial library would contain a broad range of bacterial species with unique metabolic 
functions that need to be further explored. Some functions of interest would be 
increased digestibility, increased VFA production, ionophore production, inhibition of 
other pathogens and increase feed efficiency. As such the library generated in this 
study is an invaluable resource for future DFM screening and development studies. 
Additionally, we identified more potent strains of bacteria with the capability to inhibit S. 
bovis and F. necrophorum however, these strains were less attractive to the industry as 
they needed to go through rigorous evaluations to obtain GRAS status. As such the 
GRAS approved strains were used for subsequent testing.   
 
The isolates identified were classified as Bacillus spp. and are able to exhibit industrial 
tolerant properties such as changes in pH, growth temperatures, and variability in 
substrates for growth.  Abriouel et al. (2011) explains how B. pumilus is not well 
characterized for its bacteriocin-like peptides. Instead, B. pumilus is able to produce a 
plasmid-encoded peptide called pumilicin which are heat stable and are active within a 
broad pH range (3-9). Thus, demonstrating the vast opportunities available to use 
Bacillus strains as DFMs.  
 
It is well documented that bacterial isolates/strains are host/environment specific (Foster 
et al., 2017) and as such develop unique features to survive in unique environments. As 
such, the isolates we have obtained from the rumen are assumed to have developed 
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unique features and therefore has a greater potential as being successful DFMs for 
ruminants and is supported by genomic features identified. 
 
In addition to identifying potential strains of DFM to decrease S. bovis and F. 
necrophorum population abundance, we have optimized growth condition to increase 
growth and probiotic potential. Optimization experiments using elevated temperatures, 
starvation, and incubation times, we identified both isolates to produce the most 
antimicrobials at 37C, shaking at 150 rpm for 48 hours in BHI medium. The plasticity of 
the isolates under different pH, temperature and starvation condition also lends 
information into the stability of the DFM developed.  This observation coincides with the 
conclusion of Abriouel et al. (2011) which also reported the metabolic plasticity of 
Bacillus strains.   
 
2.5.2 The DFM developed is capable of reducing the abundance of F. 
necrophorum in the rumen 
The in vivo study, conducted at USMARC (Clay Center, NE), using 296 fed cattle in a 
179 day feeding trial receiving B. pumilus for 89 days demonstrated a significant 
decrease in F. necrophorum abundance in the DFM fed cattle compared to control 
animals. The 100 fold decrease in F. necrophorum, we saw within the first rumen 
sampling, suggest the current DFM is effective in helping decrease F. necrophorum in 
beef cattle. However, the cocktail we fed during the second part of the feeding trial was 
not effective as realtime PCR results for that period did not indicate a significant 
decrease in F. necrophorum abundance similar to the first half of the trial. Additionally, 
liver abscess scores recorded at harvest did not show a significant effect of the DFM on 
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liver abscesses. We believe the decrease effectiveness could be due to several 
reasons; 1) the concentration of DFM fed may have been too low to affect function in 
the rumen where the volume and concentration of other microbial species is high and 
have significant competition for resources, 2) the DFM cocktail would have been less 
effective than feeding just B. pumilus, and finally, 3) the cattle may have not been in an 
environment where it needed to compete for a niche or fed a high enough concentrate 
diet to induce liver abscesses. As such, the occurrence of liver abscesses even in the 
control pens were 18.44% and are similar to the level of liver abscessed observed in the 
industry with feeding of Tylan (McKeith et al., 2012). It is well documented that liver 
abscesses could occur early or late in the feeding period (Nagaraja et al., 2007). Within 
this study, we only sampled at two time periods in order to try to capture both the early 
and late effects that we were hoping to see. Therefore, with our results we believe more 
frequent sampling is needed to understand the relationship between F. necrophorum 
abundance and liver abscesses. Additionally, we believe measuring host immune 
responses, longitudinally, may also provide insight into when liver abscess formation 
mostly occurs and what is the best time for intervention.  As such we believe, looking at 
white blood cell counts, could be an indicator for when F. necrophorum influx occurs 
and give a “in time” indication of the effectiveness of a DFM intervention. Macdonald et 
al. (2017) demonstrated the use of blood collection in comparison to determine cattle 
with liver abscesses prior to harvest. This group suggested cattle with elevated levels of 
blood cortisol and AST as well as lower levels of blood albumin and cholesterol 
indicated a higher chance of having abscesses. Further investigation on the precise 
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concentration of DFM needed to have optimal effect within the rumen is another factor 
that needs to be investigated.  
 
2.5.3 Genomic and metabolic features of the DFMs isolated 
Logan et al. (1984) used an API identification testing for identification of Bacillus 
species. In this study, Logan et al. (1984) evaluated 81 strains of B. licheniformis and 63 
strains of B. pumilus and identified core metabolism present within each species. The 
API testing of the DFM strains in this study was tested against 48 substrates and was 
compared to the results described by Logan et al. (1984). The B. licheniformis (12F) 
displayed similar substrate utilization patterns to Logan et al. (1984) (Table 5). However, 
12F utilized melibiose whereas Logan et al. (1984) did not see the utilization of this 
substrate by the strains tested. Melibiose is a disaccharide consisting of one galactose 
and glucose moiety in an alpha (1-6) linkage and is suggested to be only metabolized 
and utilized by gut microflora (PubChem 
(https://pubchem.ncbi.nlm.nih.gov/compound/D-Melibiose). 
 
B. pumilus (11E) demonstrated larger differences in fermentation results compared to 
Logan et al. (1984) (Table 5) where, maltose and D-turanose were utilized by 11E but 
not in the strains from Logan et al. (1984). D-turanose is composed of fatty acyl 
glycosides mono- and disaccharides (https://hmdb.ca/metabolites/HMDB0011740). 
Maltose is the result from the breakdown of starches. Thus, leading us to hypothesize 
that 11E would be able to survive under high starch conditions in the rumen. 
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Additionally, sorbitol, glycogen, and xylitol were not utilized by strains analyzed in Logan 
et al. (1984) study but was utilized by strain 11E.  
 
Multiple bacteriocins were found during genome scanning for bacteriocins using the 
BAGEL4 database. The results demonstrated that four bacteriocins were identified in 
the B. pumilus genome and five for B. licheniformis. Interestingly, among the 
bacteriocins found in B. pumilus, UviB gene was identified from both BAGEL4 and 
bactibase searches. UviB is reported to be expressed by UV irradiation 
(https://www.uniprot.org/uniprot/P15936). Searching the NCBI database using Blastn 
search parameters, the UviB gene sequence was identified in Bacillus species such as 
B. safensis and B. altitudinis. Additionally, UviB has been seen in a Brevibacillus 
laterosporus species and is thought to help Brevibacillus laterosporus inhibit gram-
positive and gram-negative multi- drug resistant pathogens (Mijkovic et al., 2019). 
Amylocyclicin was another bacteriocin found within the B. pumilus genome. Scholz et al. 
(2014) describe this bacteriocin as a ribosomally synthesized circular bacteriocin which 
is capable of inhibiting gram-positive bacteria. Interestingly, Abriouel et al. (2011) found 
B. pumilus to produce a bacteriocin called pumilicin however, we did not see this 
bacteriocin within our “11E” specific strain.  
 
We identified 5 potential bacteriocins within the B. licheniformis genome. Sororensin 
that was identified is thought to be a bacitracin capable of inhibiting biofilms and act as 
a food bioperservative. As such, Chopra et al. (2015) demonstrates the effects of 
bacteria with sororensin production to inhibit opportunistic biofilm pathogens. This 
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suggests that B. licheniformis may be able to inhibit biofilm forming pathogens much like 
what was seen in Chorpra et al. (2015) study. Additionally, B. licheniformis genome also 
contained three different Lichenicidin genes which are commonly associated with 
various B. licheniformis species. As such, this type of bacteriocins are known as a two-
component lantibiotics that inhibits the growth of pathogens such as Staphylococcus 
aureus (MRSA) (Caetano et al., 2011).  
 
Both B. pumilus and B. licheniformis possess the antimicrobial gene BmbF. However, 
little information was found on the mode of action for this gene. BmbF falls within the 
class of Sactipeptides. According to Grove et al. (2017) this peptide class is a typically 
co-localized in operons with members of radical S-adenosyl-L-methionine (SAM) 
enzyme of which is required for biosynthesis. As such, the bacteriocins identified in both 
B. pumilus and B. licheniformis could provide clues into how these strains could inhibit 
F. necrophorum and S. bovis. Still, further investigation and complete genome analysis 
is needed. Finally, the in vitro digestibility study did not show any negative effects of the 
DFM on animal performance or digestibility. As such the DFMs developed in this study 
has great potential to be used as a DFM. However, further studies are needed to 
estimate dosage and evaluate colonization and persistence of the DFM in the rumen.   
 
2.6 Conclusions 
Direct fed microbials offer an array of applicable practices that may not only improve 
health but also livestock performance. Adjusting host microbiomes to allow 
establishment may propose implications for the use of DFM. However, isolation 
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methods from hosts may be one option to avoid this problem. Additionally, increasing 
the samplings and pinpointing the exact time peak influx of Fusobacterium necrophorum 
necrophorum occurs, may be more indicative for finding the correct concentration to 
feed DFM.  
 
2.7 Future Directions 
An in vivo study is currently being investigated at the University of Nebraska-Lincoln 
Individual Barn in Mead, Nebraska. There are 58 head of cattle on trial with two cohort 
groups of control and DFM. Of which, the DFM cohort (n=29) is being fed a cocktail of 
Bacillus pumilus and Bacillus licheniformis at 81 billion cells per head per day for 
roughly 182 days. Five jugular blood samplings will be taken and analyzed for white 
blood cell counts to estimate acidosis and liver abscess formation prior to harvest. 
Cattle will be liver scored post-harvest.  
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2.9 Appendix I Tables 
 
Table 1. Diet information for the six animals from which rumen fluid was collected to 
generate the for isolation library.  
Table 1a. 
1 Supplement included 0.74% Fine Ground Corn, 1.73% Limestone, 0.16% Tallow, 
1.52% Urea, 0.47% Potassium Chloride, 1.50% Corn Gluten Meal, 0.30% Salt, 0.05% 
Beef Trace Mineral, 0.02% Vitamin A-D-E, 0.02% Rumensin-90, and 0.01% Tylan-40. 
 
Table 1b. 
Ingredients  % Diet Dry Matter 
Dry Rolled Corn 24.00 
High Moisture Corn 24.00 
MDGS Deoiled 40.00 
Alfalfa 3.00 
Sorghum Silage 4.00 
Supplement2 5.00 
2 Supplement included 2.79% Fine Ground Corn, 1.70% Limestone, 0.13% Tallow, 
0.30% Salt, 0.05% Beef Trace Mineral, 0.02% Vitamin A-D-E, 0.02% Rumensin-90, and 
0.01% Tylan-40. 
 
Table 1c. 
Ingredients  % Diet Dry Matter 
Dry Rolled Corn 24.00 
High Moisture Corn 24.00 
MDGS Deoiled 38.00 
Corn Oil 2.00 
Alfalfa 3.00 
Sorghum Silage 4.00 
Supplement2 5.00 
2 Supplement included 2.79% Fine Ground Corn, 1.70% Limestone, 0.13% Tallow, 
0.30% Salt, 0.05% Beef Trace Mineral, 0.02% Vitamin A-D-E, 0.02% Rumensin-90, and 
0.01% Tylan-40. 
 
Table 1d. 
Ingredients  % Diet Dry Matter 
Dry Rolled Corn 24.00 
High Moisture Corn 24.00 
MDGS Full Fat 40.00 
Ingredients  % Diet Dry Matter 
Dry Rolled Corn 43.25 
High Moisture Corn 43.25 
Alfalfa 3.00 
Sorghum Silage 4.00 
Supplement1 6.50 
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Alfalfa 3.00 
Sorghum Silage 4.00 
Supplement2 5.00 
2 Supplement included 2.79% Fine Ground Corn, 1.70% Limestone, 0.13% Tallow, 
0.30% Salt, 0.05% Beef Trace Mineral, 0.02% Vitamin A-D-E, 0.02% Rumensin-90, and 
0.01% Tylan-40. 
 
Table 1e. 
Ingredients  % Diet Dry Matter 
Dry Rolled Corn 33.75 
High Moisture Corn 33.75 
Alfalfa 7.500 
WDGS 20.00 
Supplement3 5.00 
3 Supplement included 2.66% Fine Ground Corn, 1.35% Limestone, 0.13% Tallow, 
0.50% Urea, 0.30% Salt, 0.05% Beef Trace Mineral, and 0.02% Vitamin A-D-E. 
 
Table 1f. 
Ingredients  % Diet Dry Matter 
Corn Silage 95.00 
Supplement3 5.00 
3 Supplement included 2.66% Fine Ground Corn, 1.35% Limestone, 0.13% Tallow, 
0.50% Urea, 0.30% Salt, 0.05% Beef Trace Mineral, and 0.02% Vitamin A-D-E. 
 
 
Table 2. Protentional Isolates characterized using full length 16S rDNA sequencing. 
The pathogens inhibited by each isolate is shown below.  
 
Isolat
e Specie 
Streptococcu
s bovis 
Fusobacteriu
m 
necrophorum 
necrophorum 
H. 
somn
i 
Manhemmni
a 
6 B. pumilus + + - - 
7 B. licheniformis + + - + 
ISP4 
P2A 
12F B. licheniformis + + - + 
ISP4 
P1A 
11E B. pumilus + + - + 
11 B. pumilus + + - - 
ISP4 
P2A 
12H B. pumilus + + - - 
P16 
B4 SR B. licheniformis + + - - 
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P5A 
C1 SR B. licheniformis - - - - 
P5A 
E1 SR Bacillus - - - - 
ISP2 
P8 D1 B. licheniformis - + - - 
ISP2 
P8 D2 B. licheniformis - + - - 
ISP2 
P8 F1 B. licheniformis - + - - 
ISP2 
P8 H2 B. licheniformis - + - - 
ISP2 
P8 G2 B. pumilus - + - - 
ISP2 
P15 
C3 B. licheniformis + - - - 
ISP2 
P16 
D6 B. licheniformis + - - - 
ISP2 
P16 
E6 B. licheniformis + - - - 
ISP2 
P16 
G2 B. licheniformis + + - - 
ISP2 
P16 
B4 B. licheniformis + + - - 
ISP4 
P2A 
F12 N/A + - - - 
ISP4 
P3A 
B7 B. licheniformis + - - - 
C/S 
P8 D5 B. licheniformis - + + - 
ISP2 
P8 G2 N/A - + - - 
ISP2 
P14 
A3 B. pumilus - + - - 
ISP2 
P14 
A4 B. pumilus - + - - 
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ISP2 
P14 
B2 B. pumilus - + - - 
ISP2 
P14 
D9 B. pumilus - + - - 
ISP2 
P14 
E5 B. pumilus - + - - 
ISP4 
P2 
A10 B. pumilus - + - - 
ISP4 
P2 
H10 N/A - - - - 
ISP4 
P3 A4 B. pumilus - + - - 
ISP4 
P3 B9 B. pumilus - + - - 
ISP4 
P3 
B11 B. pumilus - + - - 
ISP4 
P3 C4 B. pumilus - + - - 
ISP4 
P3 G7 B. pumilus - + - - 
ISP4 
P1A 
B5 B. pumilus - + - - 
ISP4 
P1A 
C4 B. pumilus - + - - 
ISP4 
P1A 
D2 B. pumilus - + - - 
ISP4 
P1A 
E1 B. pumilus - + - - 
ISP4 
P1A 
E4 B. pumilus - + - - 
ISP4 
P1A 
B2 B. pumilus - + + - 
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ISP4 
P2A 
B1 B. pumilus - + - - 
ISP4 
P2A 
C2 B. pumilus - + - - 
ISP4 
P2A 
C7 B. pumilus - + - - 
ISP4 
P2A 
D6 B. pumilus - + - - 
ISP4 
P2A 
E6 B. pumilus - + - - 
ISP4 
P2A 
F6 B. pumilus - + - - 
ISP4 
P2A 
H8 B. pumilus + - - - 
ISP4 
P2A 
H12 N/A - - - - 
ISP4 
P6A 
G1 B. pumilus + - - - 
C/S 
P7 A6 B. pumilus - + - - 
C/S 
P5A 
B1 B. pumilus + - - - 
C/S 
P5A 
C6 B. pumilus - + - - 
C/S 
P5A 
G1 B. pumilus + - - - 
C/S 
P5A 
H2 B. pumilus - + - - 
C/S 
P6A 
H1 B. pumilus + - - - 
C/S 
7A 5A B. pumilus + - - - 
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C/S 
7A C3 B. pumilus + - - - 
ISP4 
P5A 
9C B. pumilus + - - - 
ISP2 
P8 A2 
B. 
gylcinifermentan
s + - - - 
ISP2 
P14 
D1 B. altitudnis - + - - 
ISP2 
P14 
H7 B. safensis - + - - 
ISP2 
P15 
B2 A. aneurinilyticus - + - - 
ISP2 
P15 
C9 A. aneurinilyticus + + - - 
ISP2 
P16 
C6 
B. 
gylcinifermentan
s + - - - 
ISP2 
P16 
F4 Brevibacilus + + - - 
ISP4 
P2 D1 B. ooleronius - + - - 
ISP4 
P2 E2 A. migulans - + - - 
ISP4 
P2 A9 B. clausii - + - - 
ISP4 
P2 
B11 B. clausii - + - - 
ISP4 
P3 E7 B. altitudnis - + - - 
ISP4 
P1A 
D3 B. altitudnis - + - - 
ISP4 
P1A 
F9 B. circulans - + - - 
ISP4 
P1A 
G9 B. safensis - + - - 
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ISP4 
P2A 
A7 B. clausii - + - - 
ISP4 
P2A 
B6 B. borstelensis - + - - 
C/S 
P7 A7 B. subtilis - + - - 
C/S 
P7 G4 A. migulans - + - - 
C/S 
P5A 
G1 B. pumilus - + - - 
C/S 
P5A 
F1 B. sonorensis + + - - 
 
 
Table 3. Results from in-vitro digestibility studies evaluating the effect of DFM on rumen 
digestibility. 
 
Table 3A.  
in vitro Dry Matter Digestibility 
Ingredients Control DFM E Coli 
Dry Rolled Corn 90.4% 93.8% 90.7% 
Total Mixed Ration 76.7% 80.9% 79.2% 
Meadow Hay 52.8% 51.8% 56.1% 
Bran 79.3% 74.6% 75.4% 
 
Table 3B. 
 
in vitro Organic Matter Digestibility 
Ingredients Control DFM E Coli 
Dry Rolled Corn 90.8% 91.1% 89.6% 
Total Mixed Ration 77.4% 82.3% 78.9% 
Meadow Hay 58.6% 58.1% 62.9% 
Bran 79.1% 75.5% 75.2% 
 
Table 4. Liver abscess data collected post-harvest. 
Treatment % Abscesses 
Control 18.4 
DFM 21.8 
 
Table 5. API results from B. licheniformis (12F) and B. pumilus (11E) after 24 hours of 
anaerobic incubation. (+ positive, - negative, + partially positive) 
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Substrate B. licheniformis B. pumilus 
Glycerol + + 
Erythritol   
D-Arabinose   
L-Arabinose + + 
Ribose + + 
D-Xylose + + 
L-Xylose   
Adonitol   
𝛽-Methylxyloside   
Galactose + + 
D-Glucose + + 
D-Fructose + + 
D-Mannose + + 
L-Sorbose   
Rhamnose +  
Dulcitol   
Inositol   
Mannitol + + 
Sorbitol + + 
𝛼-Methyl-D-mannoside   
𝛼-Methyl-D-glucoside  + 
N-Acetylglucosamine + + 
Amygdalin + + 
Arbutin  + 
Aesculin + + 
Salicin + + 
Cellobiose + + 
Maltose + + 
Lactose + + 
Melibiose +  
Sucrose + + 
Trehalose  + 
Inulin  + 
Melezitose  + 
D-Raffinose  + 
Starch  + 
Glycogen  + 
Xylitol  + 
𝛽-Gentiobiose  + 
D-Turanose +  
D-Lyxose   
D-Fucose   
L-Fucose   
D-Arabitol   
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L-Arabitol  + 
Gluconate   
2-Ketagluconate  + 
5-Ketogluconate   
 
 
Table 6. Genome assembly statistics for B. pumilus and B. licheniformis. 
 
 B. pumilus B. licheniformis 
# contigs (> = 0 bp) 245 215 
# contigs (> = 1000 bp) 21 21 
# contigs (> = 5000 bp) 13 13 
# contigs (> = 10000 bp) 11 11 
# contigs (> = 25000 bp) 9 9 
Total length (> = 50000 bp) 9 9 
Total length (> = 0 bp) 3830136 3817708 
Total length (> = 1000 bp) 3738374 3738922 
Total length (> = 5000 bp) 3725698 3724640 
Total length (> = 10000 bp) 3710277 3709219 
Total length (> = 25000 bp) 3671113 3670055 
Total length (> = 50000 bp) 3671113 3670055 
# contigs 21 55 
Largest contig 962803 962803 
Total length 3738374 3760977 
N50 478599 477432 
 
 
Table 7. ANI results for B. licheniformis and B. pumilus. 
 
Table 7a.  
 
 
Template p_value Total 
query 
coverag
e 
Total 
templat
e 
coverag
e 
Total 
dept 
Description TaxID Species 
GCF_001896025.1_A
SM189602v1 1.01E-22 87.05 96.71 0.97 NZ_CP018249.1 
185640
6 
Bacillus sp. 
H15-1 
GCF_003253815.1_A
SM325381v1 1.01E-22 86.88 95.89 0.96 
NZ_CP021970.1
1402 1402 
Bacillus 
licheniformis 
CBA7132 
GCF_002074075.1_A
SM207407v1 1.01E-04 86.66 94.11 0.94 NZ_CP014795.1 1402 
Bacillus 
licheniformis 
GCF_002236895.1_A
SM223689v1 1.01E-22 86.34 93.65 0.94 NZ_CP022477.1 1402 
Bacillus 
licheniformis 
GCF_001726125.1_A
SM172612v1 1.01E-22 85.74 91.79 0.91 NZ_CP017247.1 1402 
Bacillus 
licheniformis 
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Table 7b. 
 
Template p_value Total 
query 
coverag
e 
Total 
templat
e 
coverag
e 
Total 
dept 
Description TaxID Species 
GCF_000800825.1_A
SM80082v1 
1.01E-22 80.98 83.22 0.83 NZ_CP010075.1 756828 Bacillus sp. WP8 
(Bacillus 
pumilus) 
GCF_001938705.1_A
SM193870v1 1.01E-22 68.66 70.24 0.70 NZ_CP015611.1 561879 Bacillus safensis 
GCF_002077215.1_A
SM207721v1 1.01E-22 55.96 57.03 0.57 NZ_CP018100.1 561879 Bacillus safensis 
GCF_001895885.1_A
SM189588v1 1.01E-17 56.72 56.04 0.56 NZ_CP018197.1 561879 Bacillus safensis 
GCF_001938665.1_A
SM193866v1 1.01E-22 55.63 55.05 0.54 NZ_CP015607.1 561879 Bacillus safensis 
 
 
 
Table 8. Diets for in vivo feeding experimental trial conducted at USMARC.  
 
Table 8a. Growing diet for cattle on feeding experimental trial.  
Ingredients % Dry Matter 
Corn 39.00% 
Corn Silage 29.00% 
Wet Distillars Grains and Soluables 28.50% 
Urea 0.00% 
Balance Pellet 3.50% 
 
Table 8b. Finishing diet for cattle on feeding experimental trial.  
Ingredients % Dry Matter 
Corn 71.75% 
Corn Silage 9.00% 
Wet Distillars Grains and Soluables 15.00% 
Urea 0.75% 
Balance Pellet 3.50% 
 
Appendix II Figures 
 
Figure 1. A representative high throughput functional screening plate against F. 
necrophorum used to identify candidates from the isolate library for further testing. 
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Figure 2. Secondary inhibition test conducted for isolates “11E” and “12F” against 
Streptococcus bovis ATCC 33317 and Fusobacterium necrophorum necrophorum 
ATCC 25286. a. Isolate ISP4 P1A 11E inhibiting Streptococcus bovis ATCC 33317. b. 
Isolate ISP4 P2A 12F inhibiting Streptococcus bovis ATCC 33317 c. Isolate ISP4 P1A 
11E inhibiting Fusobacterium necrophorum necrophorum ATCC 25286 d. Isolate ISP4 
P2A 12F inhibiting Fusobacterium necrophorum necrophorum ATCC 25286. All tests 
were performed on BHI agar plates and inhibition was observed after 24hrs of growth 
under anaerobic conditions. The cells of interest are circled in red. 
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Figure 3.  Representative results from flow cytometry analysis after live/dead staining. 
The cell counts were used to determine the amount of cells present on cultured to 
determine feeding concentrations. Panel A shows the gate set for counting cells, panel 
B shows the live, dead, damaged bacterial cell populations identified. Panel C shows 
A B 
C
 
D 
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absolute cell counts and distribution. Panels D & E shows the gate and the population of 
control beads identified by cell cytometry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C 
D  
E 
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Figure 4.  
Realtime PCR analysis results for abundance of F. necrophorum in rumen samples 
collected from the in-vivo trial conducted at United States Meat Animal Research Center 
(USMARC) to investigate the efficacy of the DFM to reduce F. necrophorum abundance 
and in turn liver abscesses in cattle. Panel 4a and 4b shows realtime PCR results for 
rumen samples collected on day 89 after feeding B. pumilus (11E) overall abundance 
and on pen-basis respectively. Panel 4c and 4d shows realtime PCR results for rumen 
samples collected on day 171 after feeding a cocktail of B. pumilus (11E) and B. 
licheniformis (12E) overall abundance and pen-basis respectively.  Pens 1-5 received a 
DFM whereas pens 6-10 were control pens. There was a significant difference in F. 
necrophorum abundance detected among treatments for the first tubing (p < 0.038) 
however, no difference was seen at second tubing (p = 0.322).  
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3 Longitudinal assessment of the bovine ocular microbiome  
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3.1 ABSTRACT 
 
A commonly found disease in the beef cattle industry is Infectious Bovine 
Keratoconjunctivitis (IBK). Better known as pinkeye, this disease has an impact of close 
to 150 million dollars annually to the beef cattle industry. However, intervention 
strategies to prevent IBK is fairly limited, with most cases resulting in treatment with 
antibiotics once the disease has developed. This is partly, due to the lack of studies 
evaluating establishment of the ocular microbiota to identify critical times of IBK 
outbreak. The understanding of the establishment and composition of the ocular 
microbiome in cattle are limited. The few studies that have investigated the ocular 
microbiome in cattle suggest that colonization by opportunistic pathogens lead to IBK 
outbreaks. In an attempt to characterize the establishment and colonization patterns of 
the bovine ocular microbiome, we conducted a longitudinal study consisting of 239 
calves using three different preventative treatments (Autogenous, Commercial, and 
Placebo) and evaluated the microbiome composition over time using 16S rDNA. A 
significant change in bacterial community composition was observed across time 
periods (p < 0.001). Where, the community reverted back to the original composition 
post perturbation and vaccination after 139 days of the initial perturbation demonstrating 
the resilience of the ocular microbiome to change once established. Additionally, 
dynamic changes in opportunistic pathogens Mycoplasma spp. and Moraxella spp. were 
observed. This study characterizes the diversity of the ocular microbiome in calves and 
demonstrates the plasticity of the ocular microbiome to change. Characterizing the 
dynamic nature of the ocular microbiome provides novel opportunities to develop 
potential probiotic intervention to reduce IBK outbreaks in cattle.  
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Key words: Infectious Bovine Keratoconjunctivitis, 16S rDNA, microbiome, Moraxella, 
Mycoplasma, probiotic 
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3.2 Introduction 
  
One of the most limiting diseases found among the beef cattle industry is Infectious 
Bovine Keratoconjunctivitis (IBK), commonly known as pinkeye (Cullen et al. 2017, 
Dickey et al., 2016). IBK impacts the beef industry with costs close to 150 million dollars 
annually, due to increased treatment cost, decreased weaning weight and decreased 
milk production (Whittier et al., 2009). The symptoms of IBK are variable and cattle with 
IBK exhibit corneal ulceration and edema. Additionally, this disease causes ocular pain 
and varying degrees of corneal scarring, corneal rupture and permanent blindness 
depending on the severity of the IBK infection (Angelos et al., 2004, Angelos et al., 
2010).  Whittier et al., (2009), reported that cattle with IBK on average weighed 19.6 lb 
less at weaning than did healthy calves. Likewise, IBK is commonly thought of as the 
most problematic disease in breeding age beef heifers, where cattle infected are more 
prone die due to starvation or due to an accident.  
 
While there are many factors that contribute to an IBK infection, Moraxella bovis and 
Mycoplasma bovoculi, are thought to predispose the animal to disease. It is suggested 
that Moraxella and Mycoplasma enter the eye via face flies or as an effect of secretion 
after irritation of the eye due to cuts from tall grass, feed, or UV light from the sun. 
Asymptomatic animals can also affect IBK as eyes, nose, and vagina are locations that 
commonly harbor Moraxella and Mycoplasma and can shed pathogens to the 
environment that can lead to infection (Whittier et al., 2009).  
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Currently, prevention for IBK has been limited to the use of vaccines (Whittier et al., 
2009, Angelos 2010, Angelos et al., 2010, & O’Connor et al., 2011).  However, the use 
of vaccines has shown variable outcomes. Thus, producers are utilizing fly tags, back 
rubbers, pour-ons and pasture management to reduce the occurrence of IBK outbreaks. 
Partly, one reason for the lack of intervention strategies for IBK control is our limited 
understanding of the ocular microbiome in cattle and how the ocular microbiome is 
established and reacts to perturbation. Additionally, what changes in the ocular 
microbiome that leads to increase in opportunistic pathogen colonization is poorly 
understood. This is mainly due to the lack of studies investigating the ocular 
microbiome. In a recent study, Cullen et al. (2017), utilized high-throughput sequencing 
of the 16S rDNA gene to compare bacterial communities of calves who developed IBK 
to calves who did not show IBK symptoms. This first study of the bovine ocular 
microbiome demonstrated no large-scale community differences between cattle infected 
with IBK and cattle with no IBK symptoms. Still, Faith’s Phylogenetic Diversity showed 
that there was a greater diversity found among cattle infected with IBK than the control 
cohort.  Additionally, Cullen et al. (2017), concluded that there was no variation in 
Moraxella sp. abundance among the two cohorts even though Moraxella was identified 
as the most abundant genera. With many studies describing the dynamic nature of the 
microbiome (Greber 2014), it is critical to monitor the microbiome over time to identify 
the stable phenotype of the microbiome and to identify “windows of opportunity” that 
increase disease susceptibility and for intervention.  Therefore, in this study, to better 
assess bacterial composition within the bovine eye, we monitored bacterial community 
changes over time. Thus, we utilized a longitudinal study to assess the bacterial 
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community which included before and after perturbation of the ocular microbiome using 
16S rDNA sequencing to identify ocular microbiome changes over time and changes 
that occur during ocular perturbation.  
 
3.3 Materials and Methods 
3.3.1 Animals  
All animal-related procedures and interventions implemented in this study were 
approved by the Institutional Animal Care and Use Committee (IACUC) at the University 
of Nebraska-Lincoln. The experimental design consisted of 239 calves (n=239) with 
three treatments of Autogenous, Commercial, and Placebo given at day zero and a 
booster at day 21. The longitudinal study consisted of 139 days with four sampling at 
day 0, 21, 41 and 139. Months for the duration of the study spanned from May 16th to 
October 2nd. The cohort of calves were composed of both male and female, red and 
black hide color, and breeds of angus or Simmental composites. Average age of calves 
on trial began at 65 and at weaning (day 139 or time 4) the average age of calves were 
204 days old.  
 
Flocked nylon swabs were used to sample the inferior ocular conjunctival surface and 
the resulting swabs were placed in modified liquid amies transport media (Eswab 
Transport System, Copan). Media was kept on ice and transported to the laboratory 
where an aliquot was frozen -80 °C until used for microbial community analysis.   
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3.3.2 DNA Extraction and Sequencing 
DNA was extracted using Lucigen Quick Extract kit (Lucigen Corporation Middleton, WI) 
according to the manufactures protocol with a modification of adding a bead beating 
step using a TissueLyser (Qiagen Inc., Valencia, CA, USA) at a frequency of 20 Hz for 
15 minutes prior to water bath incubations at 65for six minutes and 98C for five 
minutes. Isolated DNA was stored at -20C until used for bacterial community analysis. 
Amplification of the V4 region of the 16S rDNA gene and sequencing using multiplexed 
barcodes was performed using the MiSeq 250 bp paired ends sequencing strategy as 
described previously (Kozich et al. 2013). Briefly, barcoded universal primers specific to 
the V4 region were used to amplify the 16S rDNA gene in 25 μl PCR reactions. Library 
preparation PCR reaction contained 0.75 Units of Terra PCR Direct Polymerase Mix 
(Clontech Laboratories Inc., Mountain View, CA, USA), 1X Terra PCR Direct Buffer 
(Clontech Laboratories Inc., Mountain View, CA, USA), 0.4 uM indexed primers, and 20-
50ng of DNA. Amplifications were performed on a Veriti 96-Well Thermocycler (Life 
Technologies, Carlsbad, CA, USA) with conditions of 98C  for 2 minutes followed by 25 
cycles of 98C for 30s, 58C for 30 seconds, 68C for 45s, with a final extension of 68℃ 
for 4 minutes.  The resulting amplicons were normalized and sequenced using the 
250bp paired end sequencing strategy using the Illumina MiSeq platform with V2 500 
cycle sequencing kit as described by the manufacturer (Illumina, San Diego, CA, USA).  
 
3.3.3 Protein Quantification and ELISA preparation 
A subset of animals were identified based on microbial community differences that 
reflect the largest changes in community structure across the time points sampled and 
  
108 
were used to evaluate bovine immunoglobulin A levels (IgA). Briefly, protein levels in 
the eye swabs were quantified using Qubit™ Protein Assay Kit (Invitrogen Carlsbad, 
CA, USA) according to the manufactures protocol and normalized protein amounts (19-
24 mg) were assayed using the Bovine IgA ELISA kit (BioMatik Corporation Cambridge 
ON, Canada) according to the manufactures protocol to evaluate bovine IgA amounts.  
 
3.4 Data Processing 
Detailed information regarding the bioinformatic analysis used including the mapping 
file, scripts, and commands can be found in the GitHub page of the Fernando Lab 
(https://github.com/FernandoLab/IBK-Year1-). The Dada2 pipeline (Callahan et al., 
2016) was used for subsequent analysis. Briefly, analysis steps were performed using R 
(R Core Team, 2019) within the phyloseq package (McMurdie and Holmes, 2013) 
following the workflow described in https://www.bioconductor.org/help/course-
marterials/2017/BioC2017/Day1/Workshops/Mircobiome/MicrobiomeWorkflowII.html. 
 
In short, low quality reads were filtered (Q score of 20) and reads were trimmed to 230 
bp length. “Unique sequences” were identified by combining identical sequences and 
error rates were estimated to evaluate read quality.  Forward and reverse reads were 
assembled to generate contigs for the V4 region. Furthermore, quality filtering was 
performed to remove sequences with ambiguous bases, incorrect contig length and 
assembly, or chimeras. SILVA reference alignment database v123 was used to assign 
taxonomy and a phylogenetic tree was generated using MOTHUR (v.1.42.1).  The 
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resulting phylip.tree was used to generate a phyloseq object which was used for further 
analysis.  
 
Any potential contaminant ASVs arising from reagent contamination were removed 
using the decontam package as described previously (Davis et al., 2018). Additionally, 
any ASV with a prevalence of only one sample were removed. All data generated in this 
project have been deposited in the NCBI sort read archive under accession number 
PRJNA600014. 
 
3.5 Statistics  
Statistical analyses were performed using the R package ‘vegan’ (Dixon et al., 2003) 
using the adonis function. The PERMANOVA analysis was performed to identify factors 
effecting microbial community structure using factors of time, age, treatment, hide color, 
breed, ulcer_postive, and sex. Additionally, a pairwise Wilcox test was used in R to look 
at differences between times of sampling. Significant differences in F. necrophorum 
abundance in qPCR analysis was performed using ANOVA. All significance was 
determined at p < 0.05. 
 
3.6 Results 
3.6.1 Changes in the bovine ocular microbiome over time 
Following quality filtering and removal of reads classified as Archaea and Eukaryota, the 
resulting data contained 862 samples with 23,647,648 reads with an average of 26,620 
reads per sample. These reads were binned into 5,275 ASVs. To evaluate bacterial 
community changes during establishment and perturbation of the ocular microbiome, 
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reads were rarefied to an even depth and was used for subsequent analysis. Changes 
in bacterial community diversity was evaluated using alpha diversity metric of observed 
ASVs and Chao1 estimates. Alpha diversity using both observed ASVs and Chao1 
estimates displayed significant differences in bacterial diversity between all-time points 
demonstrating the dynamic and rapid changes in the bovine ocular microbiome. The 
least diversity was identified 3 weeks after the initial perturbation of the eye and at 
subsequent sampling the diversity increased over time reaching diversity levels greater 
than before perturbation of the eye (Figure 1).  
 
To further evaluate global changes in the ocular bacterial community over time, a 
principal component analysis was performed on the normalized data using a weighted 
UniFrac distance matrix (Lozupone et al., 2011). The PERMANOVA analysis reveal 
significant differences in bacterial community composition between time period sampled 
(p < 0.001), days old (p = 0.011), and cattle who showed positive signs of ocular ulcers 
(p = 0. 0.032). However, treatment (p = 0.491), hide color (p = 0.383), sex (p = 0.407), 
and breed (p = 0.162) did not show significant effect (Table 1, Figure 2) on bacterial 
community composition. Interestingly, time points 1 & 4 and 2 & 3 displayed similar 
bacterial community to each other respectively but were significantly different from each 
other (1&4 vs 2&3). This suggests the bacterial community is changing after 
perturbation and is reaching a community similar to before perturbation over time. To 
further evaluate this observation, we performed a hierarchical clustering of the bacterial 
communities. This analysis also displayed a similar result of bacterial communities 
changing after perturbation to establish the community before perturbation.      
  
111 
 
3.6.2 Core measurable microbiome in the bovine ocular microbiome 
It is well documented that the microbiome varies between individuals (Gerber 2014). As 
such, to look beyond variation in the microbiome and to identify the core bacterial 
community present within the ocular microbiome, we identified the core measurable 
microbiome (CMM) by identifying ASVs that were present in at least 80% of total 
samples collected. This analysis only identified three ASVs to be part of the CMM. 
These core ASVs accounted for 81% of total reads in the dataset. The ASVs 
represented genera of Preveotella, Mycoplasma, and family Weeksellacea.  The 
distribution of the core ASVs across time points is shown in Figure 3. To further 
evaluate the clustering of bacterial communities shown in the principal component 
analysis, we identified core microbial ASVs present in each time point using a criteria of 
ASVs represented in 75% of the animals in each time point. For time period one 25 
ASVs were identified, accounting for 39% of the total reads. Similarly, 3, 5, and 23 
ASVs accounting for 81%, 81%, 85% of the total reads for each time point was 
identified for time periods two, three, and four respectively.  Hierarchical clustering of 
this core ASVs based on abundance displayed clear clustering based on time point 
where, time periods 2 and 3 clustered closely together whereas, timepoints 1 and 4 
clustered together away from time points 2 and 3 (Figure 4). The major genera driving 
this difference included Preveotella, Mycoplasma, and Moraxella. Preveotella and 
Mycoplasma which appear to be in inverse of each other. Additionally, Preveotella was 
higher in abundance during time periods 2&3 and Mycoplasma as well as Moraxella 
were in higher abundance during time periods 1&4.  
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This analysis further confirmed the structuring of bacterial communities by time and also 
suggested that in time points 2 and 3 that the community is changing rapidly with loss of 
diversity as the few core ASVs identified represented 81% and 81% of the total reads 
sequenced.  
 
3.6.3 Relationship between bacterial ASVs and IBK outbreak 
During the study period, a few cattle were identified with IBK and were treated. Cattle 
treated for IBK during the study were given an ulcer score. Of the 239 animals, only 20 
animals were infected with IBK. We evaluated the bacterial community composition of 
the animals treated for IBK using the sampling time points collected before IBK infection 
and after IBK infection using a weighted UniFrac distance matrix. The PCoA plot 
displayed clustering based on if the sample was collected before or after IBK infection 
(Figure 5). PERMANOVA analysis did detect a significant change (p < 0.035) in the 
overall structure of the bacterial community suggesting a composition shift during pink 
eye infection. Further analysis of the differential ASVs identified before and after IBK 
infection displayed differences in abundances of differential ASVs over time. More 
specifically, those ASVs belonged to Family of Ruminococcaceae and Lachnospiraceae 
with an increase in abundance post infection. (Figure 6).   
 
3.6.4 Abundance of known IBK predisposers in the bovine ocular microbiome  
Previous studies have reported Mycoplasma spp. and Moraxella spp.  to be the major 
pathogens that predispose cattle to IBK. Therefore we evaluated the abundance of 
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Mycoplasma spp. and Moraxella spp.. The mean abundance of these taxa are shown in 
Figure 7. Although the relative abundance was low, Moraxella spp. were identified on all 
time points, with the highest abundance during the first time period. However, 
Mycoplasma abundance was much greater than the abundance of Moraxella with the 
highest abundance of almost 50% in time period four.  
 
3.6.5 Effect of Immunoglobulin A (IgA) on structuring of the bovine ocular 
bacterial community 
Previous reports in the human ocular microbiome has suggested IgA levels within the 
eye has an effect on the ocular microbiome (Ozkan and Wilcox 2019). To evaluate if the 
effect of IgA on the ocular microbiome was enhanced post perturbation, we evaluated 
IgA levels in animals with significantly different ocular bacterial community structure.  
IgA concentrations did not differ in animals with different bacterial community 
composition suggesting IgA concentration was not a driver of the ocular microbiome in 
this study (Figure 8). which showed no significant difference among time periods of IgA 
concentration when ocular swabs were taken. 
 
3.7 Discussion 
IBK outbreaks have continued to have economic consequences to the beef cattle 
industry. With the lack of effective preventative methods to control IBK, the cattle 
industry is faced with the challenge of developing novel methods to control and mitigate 
IBK outbreaks. There has been an increasing emphasis on microbiome investigations to 
harness the therapeutic potential of the microbiome. As such, novel opportunities may 
be available to develop novel methods to control and monitor IBK outbreaks in cattle. In 
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this study we investigated the bovine ocular microbiome over time to evaluate the 
bacterial compositional changes in the ocular microbiome before and after subsequent 
perturbations to investigate the dynamic and resilience nature of the ocular microbiome. 
We phenotyped the microbiome using 16S rDNA based sequencing of the V4 region 
using the Illumina MiSeq platform using 250 bp paired-end sequencing strategy.   
 
3.7.1 The window for re-establishment of the ocular microbiome is long 
The bovine ocular microbiome changed significantly over the 4 time periods sampled, 
which was during peak IBK periods. Where, the diversity of the microbiome dramatically 
decreased after swabbing and was very low when sampled 21 days after the first 
swabbing. At 41 days post swabbing (after the second swabbing) the bacterial diversity 
slightly increased relative to the first swabbing but remained significantly low compared 
to the initial swabbing. However, with time the bacterial diversity increased and re-
established at diversity levels similar to initial swabbing after 139 days post swabbing 
(Figure 1).  This demonstrates that when a change in the bovine ocular microbiome 
occurs, it takes a long time for the microbiome to re-establish to stable levels prior to the 
perturbation. As such, this suggests that it is possible that perturbations of the ocular 
microbiome due to environmental factors such as cuts from tall grass, feed, or UV light 
from the sun (Whittier et al., 2009) can lead to changes in the ocular microbiome that 
provide a window of opportunity for opportunistic pathogens such as Moraxella spp. and 
Mycoplasma spp. to establish and lead to IBK. 
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Further evaluation of factors that influence the ocular bacterial community in cattle using 
PERMANOVA analysis revealed time (p < 0.001), days old (p = 0.011), and cattle who 
showed positive signs of ocular ulcers (p = 0. 032) to be significant drivers of the 
bacterial community. Previous studies have reported the human ocular microbiome to 
be low in both bacterial diversity and abundance (Ozkan et al., 2017).This observation 
was consistent with the bovine ocular microbiome where diversity estimates were lower 
than the estimates reported from the rumen and fecal microbiota in cattle (Figure 1) 
(Ozkan et al., 2017). Additionally, we observed a greater decrease in the microbiome 
with perturbation of the eye. Many of the studies investigating the ocular microbiome 
has performed single point analysis and therefore have not investigated the changes 
over time (Cullen et al., 2017). As such, to our knowledge this is the first report of the 
changes and re-establishment of the ocular bacterial community over time as a result of 
perturbation. Interestingly, the bovine ocular microbiome has a higher represented 
population of bacteria in comparison to what has been published in human literature 
(Ozkan and Wilcox 2019, Ozkan et al., 2017).  
 
3.7.2 Core taxa present within the bovine ocular bacterial community 
The core microbiome analysis identified 3 ASVs to be part of the CMM that accounted 
for a major proportion of the reads sequenced (Figure 3). These core ASVs included 
three opportunistic pathogens Preveotella, Mycoplasma, and Weeksellacea. In a study 
conducted by Haung et al. (2016), the conjunctiva of adult humans were sampled. The 
results from this study found that genera related to Corynebacterium and 
  
116 
Pseudomonads were the primary bacteria found among samples (n=31) and concluded 
that bacteria found among the eye, are typically deemed as opportunistic pathogens.  
In addition to identifying core bacterial taxa present within all-time points to identify 
autochthonous bacterial species within the ocular microbiome, we identified core 
bacterial taxa present within each time period sampled. This analysis identified 36 
unique ASVs across the 4 sampling periods. Interestingly, 31 of these ASVs belonged 
to Phylum Firmicutes, Bacteroidetes, or Proteobacteria, which constituted for 86% of the 
core group. Of the three major phyla making up this core group, two-thirds belong to 
opportunistic pathogen groups with phylum Bacteroidetes being the only group with 
health benefits suggesting that the core bacterial community within the eye may harbor 
a major proportion of opportunistic pathogens which may respond to environmental 
changes and physical damages that lead to IBK and other eye related diseases. This 
observation of low diversity and predominance of Firmicutes, coincides with 
observations reported in the human ocular microbiome where genus Staphylococcus 
has been reported to predominate (Ozkan and Wilcox 2019 and Ozkan et al., 2017).   
Analysis of core ASVs share across the different time points revealed that out of the 25 
core ASVs were identified during baseline sampling, only 2,4, and 13 of these ASVs 
overlapped with bacterial communities identified in time points 2,3 and 4.  Similarly, 3, 5, 
and 23 ASVs accounting for 81%, 81%, 85% of the total reads for each time point was 
identified for time periods two, three, and four respectively.  Hierarchical clustering of 
this core ASVs based on abundance displayed clear clustering based on time pointy 
where, time periods 2 and 3 clustered closely together whereas, timepoints 1 and 4 
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clustered together away from time points 2 and 3 (Figure 4). The major families driving 
this difference included Preveotella, Mycoplasma, and Moraxella.  
 
3.7.3 Shifts in the ocular bacterial community in response to IBK  
The study was designed to evaluate microbiome composition over time in a cattle 
cohort. However, we identified a small subgroup of cattle that were infected with IBK 
and underwent treatment. The ulcer scores recorded for cattle with IBK infection, when 
analyzed with respect to the weighted UniFrac distance matrix, scores displayed a 
negative /positive correlation where the higher/lower UniFrac scores were significantly 
correlated with increased ulcer size. This suggests changes in the bacterial community 
is associated with size of ulcer and in-turn disease severity. Additionally, the PCoA plot 
displayed some clustering based on, if the sample was collected before or after IBK 
infection (Figure 5). Suggesting a microbial community shift during IBK infection. Due to 
small number of animals being infected in this study we were unable to further pursue 
this question as to which features in the microbiome may be indicators of IBK infection 
or may predispose animals to IBK.  
 
3.7.4 Mycoplasma and Moraxella are common inhabitants of the bovine ocular 
microbiome  
Current literature suggests Moraxella and Mycoplasma to be the major predisposers of 
IBK which then allows for other opportunistic pathogens to cause infection (Angelos 
2010, Loy and Brodersen 2014, & Zheng et al. 2019). We identified both Moraxella spp. 
and Mycoplasma spp. during all time points sampled, suggesting that these two genera 
may be commensals of the bovine ocular microbiome. Similar to this study, Cullen et al. 
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(2017) observed Moraxella to be one of the most abundant genera in the bovine ocular 
microbiome. Additionally, the correlation analysis displayed a somewhat negative 
correlation between the two genera suggesting these two genera may be competing for 
similar resources and niches within the ocular microbiome.   
 
Previous reports in the human ocular microbiome has suggested the IgA levels in the 
eye to effect structuring of the ocular microbiome (Ozkan et al., 2017). We investigated 
the effect of IgA on ocular microbiome using ocular swab samples from animals with 
significantly different ocular bacterial communities. IgA concentrations did not differ in 
animals with different bacterial community composition suggesting IgA concentration 
was not a driver of the ocular microbiome in this study (Figure 8).  
The cattle used in this study was not the same age at sampling (Supplementary Figure 
S1). However, the ocular microbiome establishes over time. Therefore, some of the 
variation in the microbiome that we are observing can be a result of the age of the 
animal. This was also clear from the significant effect of age seen in the beta-diversity 
analysis. Our observation is consistent with a study performed by Wen et al. (2017) as 
this group reported that the human ocular microbiome changes with age. As such, this 
study also lends information into the establishment of the ocular microbiome with age. 
Data from this study suggests the ocular microbiome establishes quickly, but recovery 
after perturbation is slow. As such future investigations of the microbiome need to be 
longitudinal. Additionally, this study also demonstrates that since the bovine ocular 
microbiome is susceptible to change, microbiome manipulation could be used to 
introduce beneficial microbes to establish a more stable and resilient microbiota.    
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3.8 Conclusion 
The understanding of the establishment and composition of the ocular microbiome in 
cattle is limited. In this study to better assess bacterial composition within the bovine 
eye, we performed a longitudinal study to evaluate bacterial community changes before 
and after perturbation of the ocular microbiome using 16S rDNA sequencing. Our 
results demonstrate that the bovine ocular microbiome has higher diversity than the 
human ocular microbiome and is slow to recover and reach stable levels after a 
perturbation event. Additionally, many factors including age, time, and ulcer infection 
effect ocular microbiome composition.  
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3.10 Appendix II 
Figure 1.  Changes in alpha diversity over time periods sampled. Observed ASVs (A) 
and Chao1 estimates (B).  Significant differences in alpha-diversity were identified 
between the sampling periods where the greatest diversity was found in time period 4. 
After initial swabbing for baseline community, the diversity significantly decreased and 
recovered over time in subsequent samplings.  
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Figure 2. Principal Coordinate analysis (PCoA) demonstrating between sample 
variations in beta-diversity. PCoA plot was generated using a weighted UniFrac 
distance matrix. PERMANOVA analysis demonstrated microbial communities to be 
significantly different based on time of sampling (p< 0.05) and is apparent in clustering 
pattern. Time points 1 and 4 demonstrated similar community structure that was 
different from time points 2 and 3. Microbial community composition and abundance in 
time points 2 and 3 were similar to each other. The major drivers of microbial 
community composition included, time of sampling, age, and ulcer positive. Color 
scheme; Red – time point 1, Green - time point 2, Teal – time point 3, and Purple – time 
point 4. 
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Figure 3. Distribution of “Core” ASVs across sampling time-points demonstrating 
predominance of opportunistic pathogens in the bovine ocular microbiome. Core 
bacterial ASVs were identified based on the presence of an ASV in at least 80% of all 
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samples. Only 3 core ASVs were identified that fell into this criteria. The core ASVs 
include; Preveotella spp. (Blue), Mycoplasma sp. (Orange) and Weeksellacea sp. 
(Grey).   
 
 
 
 
 
 
 
Figure 4. Heat-map showing the distribution of “Core” ASVs representing each time 
period. Hierarchical clustering of ASV abundance based on sampling time period clearly 
shows clustering based on sampling period. Red and purple represent sampling periods 
1 and 4 and green and blue represent time periods 2 and 3.  Samples were individually 
clustered using hierarchical clustering based on time period. The top 4 most abundant 
ASVs (4A) and the remaining top 32 ASVs (4B) are shown. Figures A and B are drawn 
using different scales due to differences in abundance. The top 4 ASVs include 
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ASV_1_Prevotella, ASV_2_Mycoplasma, ASV_3_Weeksellaea, and 
ASV_7_Ruminococcacaea.  
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Figure 5. Principal Coordinate analysis (PCoA) demonstrating microbial community 
differences before and after ulcer formation. A significant difference in community 
composition was detected when samples before infection and after ulcer formation was 
analyzed. The PCoA was performed using a weighted UniFrac distance matrix. Color 
scheme; Teal –before ulcer and Red- after ulcer. 
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Figure 6. Heat-map showing differential ASVs identified within the bacterial community 
of ulcer positive animals before and after IBK infection. The major differences in 
community structure was driven by ASVs belonging to family Lachnospiraceae and 
Ruminococcaceae. 
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Figure 7.  Distribution of opportunistic pathogens Moraxella spp. and Mycoplasma spp. 
across the 4 sampling time points.  Moraxella spp. and Mycoplasma spp. are 
considered as opportunistic pathogens that predispose animals to IBK infection.  
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Figure 8. Association between IgA concentration and time the ocular swab was taken. 
No change in IgA concentration was detected in animals overtime or age. 
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Supplementary Material  
Supplementary S1. Distribution of the calves age throughout trial.  
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